
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Testing the nonclinical Comprehensive In Vitro Proarrhythmia Assay (CiPA) paradigm with an established anti‐seizure medication: Levetiracetam case study - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="ABCB5CFD92766A633E5CFD001F624CD3.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="pharmrespersp">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9903303/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Pharmacology Research &amp; Perspectives">
<meta name="citation_title" content="Testing the nonclinical Comprehensive In Vitro Proarrhythmia Assay (CiPA) paradigm with an established anti‐seizure medication: Levetiracetam case study">
<meta name="citation_author" content="Annie Delaunois">
<meta name="citation_author_institution" content="Development Sciences, UCB Biopharma SRL, Braine‐l&#x27;Alleud, Belgium">
<meta name="citation_author" content="François‐Xavier Mathy">
<meta name="citation_author_institution" content="Development Sciences, UCB Biopharma SRL, Braine‐l&#x27;Alleud, Belgium">
<meta name="citation_author" content="Miranda Cornet">
<meta name="citation_author_institution" content="Development Sciences, UCB Biopharma SRL, Braine‐l&#x27;Alleud, Belgium">
<meta name="citation_author" content="Vitalina Gryshkova">
<meta name="citation_author_institution" content="Development Sciences, UCB Biopharma SRL, Braine‐l&#x27;Alleud, Belgium">
<meta name="citation_author" content="Chloé Korlowski">
<meta name="citation_author_institution" content="Development Sciences, UCB Biopharma SRL, Braine‐l&#x27;Alleud, Belgium">
<meta name="citation_author" content="François Bonfitto">
<meta name="citation_author_institution" content="Patient Safety, UCB Biopharma SRL, Braine‐l&#x27;Alleud, Belgium">
<meta name="citation_author" content="Juliane Koch">
<meta name="citation_author_institution" content="Patient Safety, UCB Biosciences GmbH, Monheim, Germany">
<meta name="citation_author" content="Anne‐Françoise Schlit">
<meta name="citation_author_institution" content="Patient Safety, UCB Biopharma SRL, Braine‐l&#x27;Alleud, Belgium">
<meta name="citation_author" content="Simon Hebeisen">
<meta name="citation_author_institution" content="B&#x27;SYS GmbH, Witterswil, Switzerland">
<meta name="citation_author" content="Elisa Passini">
<meta name="citation_author_institution" content="Department of Computer Science, University of Oxford, Oxford, UK">
<meta name="citation_author" content="Blanca Rodriguez">
<meta name="citation_author_institution" content="Department of Computer Science, University of Oxford, Oxford, UK">
<meta name="citation_author" content="Jean‐Pierre Valentin">
<meta name="citation_author_institution" content="Development Sciences, UCB Biopharma SRL, Braine‐l&#x27;Alleud, Belgium">
<meta name="citation_publication_date" content="2023 Feb 7">
<meta name="citation_volume" content="11">
<meta name="citation_issue" content="1">
<meta name="citation_firstpage" content="e01059">
<meta name="citation_doi" content="10.1002/prp2.1059">
<meta name="citation_pmid" content="36748725">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9903303/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9903303/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9903303/pdf/PRP2-11-e01059.pdf">
<meta name="description" content="Levetiracetam (LEV), a well‐established anti‐seizure medication (ASM), was launched before the original ICH S7B nonclinical guidance assessing QT prolongation potential and the introduction of the Comprehensive In Vitro Proarrhythmia Assay (CiPA) ...">
<meta name="og:title" content="Testing the nonclinical Comprehensive In Vitro Proarrhythmia Assay (CiPA) paradigm with an established anti‐seizure medication: Levetiracetam case study">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Levetiracetam (LEV), a well‐established anti‐seizure medication (ASM), was launched before the original ICH S7B nonclinical guidance assessing QT prolongation potential and the introduction of the Comprehensive In Vitro Proarrhythmia Assay (CiPA) ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9903303/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="9903303">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1002/prp2.1059"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/PRP2-11-e01059.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9903303%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/9903303/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/9903303/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9903303/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-pharmrespersp.jpg" alt="Pharmacology Research &amp; Perspectives logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Pharmacology Research &amp; Perspectives" title="Link to Pharmacology Research &amp; Perspectives" shape="default" href="http://onlinelibrary.wiley.com/journal/10.1002/%28ISSN%292052-1707" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Pharmacol Res Perspect</button></div>. 2023 Feb 7;11(1):e01059. doi: <a href="https://doi.org/10.1002/prp2.1059" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1002/prp2.1059</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Pharmacol%20Res%20Perspect%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pharmacol%20Res%20Perspect%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Pharmacol%20Res%20Perspect%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Pharmacol%20Res%20Perspect%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Testing the nonclinical Comprehensive In Vitro Proarrhythmia Assay (CiPA) paradigm with an established anti‐seizure medication: Levetiracetam case study</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Delaunois%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Annie Delaunois</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Annie Delaunois</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Development Sciences, UCB Biopharma SRL, Braine‐l'Alleud, Belgium</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Delaunois%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Annie Delaunois</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mathy%20FX%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">François‐Xavier Mathy</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">François‐Xavier Mathy</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Development Sciences, UCB Biopharma SRL, Braine‐l'Alleud, Belgium</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mathy%20FX%22%5BAuthor%5D" class="usa-link"><span class="name western">François‐Xavier Mathy</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cornet%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Miranda Cornet</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Miranda Cornet</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Development Sciences, UCB Biopharma SRL, Braine‐l'Alleud, Belgium</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cornet%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Miranda Cornet</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gryshkova%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Vitalina Gryshkova</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Vitalina Gryshkova</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Development Sciences, UCB Biopharma SRL, Braine‐l'Alleud, Belgium</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gryshkova%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Vitalina Gryshkova</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Korlowski%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Chloé Korlowski</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Chloé Korlowski</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Development Sciences, UCB Biopharma SRL, Braine‐l'Alleud, Belgium</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Korlowski%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chloé Korlowski</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bonfitto%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">François Bonfitto</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">François Bonfitto</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Patient Safety, UCB Biopharma SRL, Braine‐l'Alleud, Belgium</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bonfitto%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">François Bonfitto</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Koch%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Juliane Koch</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Juliane Koch</span></h3>
<div class="p">
<sup>
<sup>3</sup>
</sup>Patient Safety, UCB Biosciences GmbH, Monheim, Germany</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Koch%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Juliane Koch</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schlit%20AF%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Anne‐Françoise Schlit</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Anne‐Françoise Schlit</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Patient Safety, UCB Biopharma SRL, Braine‐l'Alleud, Belgium</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schlit%20AF%22%5BAuthor%5D" class="usa-link"><span class="name western">Anne‐Françoise Schlit</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hebeisen%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Simon Hebeisen</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Simon Hebeisen</span></h3>
<div class="p">
<sup>
<sup>4</sup>
</sup>B'SYS GmbH, Witterswil, Switzerland</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hebeisen%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Simon Hebeisen</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Passini%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Elisa Passini</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Elisa Passini</span></h3>
<div class="p">
<sup>
<sup>5</sup>
</sup>Department of Computer Science, University of Oxford, Oxford, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Passini%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Elisa Passini</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rodriguez%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Blanca Rodriguez</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Blanca Rodriguez</span></h3>
<div class="p">
<sup>
<sup>5</sup>
</sup>Department of Computer Science, University of Oxford, Oxford, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rodriguez%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Blanca Rodriguez</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Valentin%20JP%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Jean‐Pierre Valentin</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Jean‐Pierre Valentin</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Development Sciences, UCB Biopharma SRL, Braine‐l'Alleud, Belgium</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Valentin%20JP%22%5BAuthor%5D" class="usa-link"><span class="name western">Jean‐Pierre Valentin</span></a>
</div>
</div>
<sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="prp21059-aff-0001">
<sup>
<sup>1</sup>
</sup>Development Sciences, UCB Biopharma SRL, Braine‐l'Alleud, Belgium</div>
<div id="prp21059-aff-0002">
<sup>
<sup>2</sup>
</sup>Patient Safety, UCB Biopharma SRL, Braine‐l'Alleud, Belgium</div>
<div id="prp21059-aff-0003">
<sup>
<sup>3</sup>
</sup>Patient Safety, UCB Biosciences GmbH, Monheim, Germany</div>
<div id="prp21059-aff-0004">
<sup>
<sup>4</sup>
</sup>B'SYS GmbH, Witterswil, Switzerland</div>
<div id="prp21059-aff-0005">
<sup>
<sup>5</sup>
</sup>Department of Computer Science, University of Oxford, Oxford, UK</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence</strong>
, 
Annie Delaunois, Development Sciences, UCB Biopharma SRL, Braine‐l'Alleud, Belgium. 
Email: <span>annie.delaunois@ucb.com</span>

</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2023 Jan 12; Received 2022 Aug 1; Accepted 2023 Jan 13; Collection date 2023 Feb.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2023 UCB Biopharma SRL. <em>Pharmacology Research &amp; Perspectives</em> published by British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics and John Wiley &amp; Sons Ltd.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC9903303  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36748725/" class="usa-link">36748725</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Levetiracetam (LEV), a well‐established anti‐seizure medication (ASM), was launched before the original ICH S7B nonclinical guidance assessing QT prolongation potential and the introduction of the Comprehensive In Vitro Proarrhythmia Assay (CiPA) paradigm. No information was available on its effects on cardiac channels. The goal of this work was to “pressure test” the CiPA approach with LEV and check the concordance of nonclinical core and follow‐up S7B assays with clinical and post‐marketing data. The following experiments were conducted with LEV (0.25–7.5 mM): patch clamp assays on hERG (acute or trafficking effects), Na<sub>V</sub>1.5, Ca<sub>V</sub>1.2, K<sub>ir</sub>2.1, K<sub>V</sub>7.1/mink, K<sub>V</sub>1.5, K<sub>V</sub>4.3, and HCN4; in silico electrophysiology modeling (Virtual Assay® software) in control, large‐variability, and high‐risk human ventricular cell populations; electrophysiology measurements in human induced pluripotent stem cell (hiPSC)‐derived cardiomyocytes and dog Purkinje fibers; ECG measurements in conscious telemetered dogs after single oral administration (150, 300, and 600 mg/kg). Except a slight inhibition (&lt;10%) of hERG and K<sub>V</sub>7.1/mink at 7.5 mM, that is, 30‐fold the free therapeutic plasma concentration (FTPC) at 1500 mg, LEV did not affect any other cardiac channels or hERG trafficking. In both virtual and real human cardiomyocytes, and in dog Purkinje fibers, LEV induced no relevant changes in electrophysiological parameters or arrhythmia. No QTc prolongation was noted up to 2.7 mM unbound plasma levels in conscious dogs, corresponding to 10‐fold the FTPC. Nonclinical assessment integrating CiPA assays shows the absence of QT prolongation and proarrhythmic risk of LEV up to at least 10‐fold the FTPC and the good concordance with clinical and postmarketing data, although this does not exclude very rare occurrence of QT prolongation cases in patients with underlying risk factors.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> cardiac safety, CiPA, ICH S7B, levetiracetam, nonclinical, QT prolongation, torsade de pointes</p></section></section><section class="abstract" id="abstract2"><hr class="headless">
<p>Levetiracetam (LEV) QT‐ogram illustrates that no biologically relevant changes (&gt;10% or 10 ms) in QT‐related biomarkers occur up to 10‐ to 30‐fold its free therapeutic plasma concentration (FTPC) in core and follow‐up CiPA/S7B nonclinical assays, and the good concordance of this nonclinical dataset with clinical data (TQT study).</p>
<section class="bt xbox font-sm" id="prp21059-blkfxd-0001"><p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2af6/9903303/51e1167a3e72/PRP2-11-e01059-g004.jpg" loading="lazy" id="jats-graphic-1" height="210" width="460" alt="graphic file with name PRP2-11-e01059-g004.jpg"></p></section></section><hr class="headless">
<h3>Abbreviations</h3>
<dl class="def-list" id="prp21059-lp-0001">
<dt id="prp21059-li-0001">AP</dt>
<dd id="prp21059-li-0002"><p>action potential</p></dd>
<dt id="prp21059-li-0003">APD</dt>
<dd id="prp21059-li-0004"><p>action potential duration</p></dd>
<dt id="prp21059-li-0005">CHO</dt>
<dd id="prp21059-li-0006"><p>Chinese Hamster Ovary</p></dd>
<dt id="prp21059-li-0007">CiPA</dt>
<dd id="prp21059-li-0008"><p>comprehensive in vitro proarrhythmia assessment</p></dd>
<dt id="prp21059-li-0009">CI</dt>
<dd id="prp21059-li-0010"><p>cell index</p></dd>
<dt id="prp21059-li-0011">CT</dt>
<dd id="prp21059-li-0012"><p>calcium transient</p></dd>
<dt id="prp21059-li-0013">CTD</dt>
<dd id="prp21059-li-0014"><p>calcium transient duration</p></dd>
<dt id="prp21059-li-0015">DMEM</dt>
<dd id="prp21059-li-0016"><p>Dulbecco's modified eagle medium</p></dd>
<dt id="prp21059-li-0017">dV/dt<sub>max</sub>
</dt>
<dd id="prp21059-li-0018"><p>maximum upstroke velocity</p></dd>
<dt id="prp21059-li-0019">EAD</dt>
<dd id="prp21059-li-0020"><p>early‐after depolarization</p></dd>
<dt id="prp21059-li-0021">EMw</dt>
<dd id="prp21059-li-0022"><p>electromechanical window</p></dd>
<dt id="prp21059-li-0023">FAERS</dt>
<dd id="prp21059-li-0024"><p>FDA adverse event reporting system</p></dd>
<dt id="prp21059-li-0025">FBS</dt>
<dd id="prp21059-li-0026"><p>fetal bovine serum</p></dd>
<dt id="prp21059-li-0027">FPD</dt>
<dd id="prp21059-li-0028"><p>field potential duration</p></dd>
<dt id="prp21059-li-0029">FTPC</dt>
<dd id="prp21059-li-0030"><p>free therapeutic plasma concentration</p></dd>
<dt id="prp21059-li-0031">GLP</dt>
<dd id="prp21059-li-0032"><p>good laboratory practice</p></dd>
<dt id="prp21059-li-0033">hiPSC‐CM</dt>
<dd id="prp21059-li-0034"><p>human induced pluripotent stem cell‐derived cardiomyocyte</p></dd>
<dt id="prp21059-li-0035">LEV</dt>
<dd id="prp21059-li-0036"><p>levetiracetam</p></dd>
<dt id="prp21059-li-0037">MRD</dt>
<dd id="prp21059-li-0038"><p>maximum rate of depolarization</p></dd>
<dt id="prp21059-li-0039">PCR</dt>
<dd id="prp21059-li-0040"><p>polymerase chain reaction</p></dd>
<dt id="prp21059-li-0041">RMP</dt>
<dd id="prp21059-li-0042"><p>resting membrane potential</p></dd>
<dt id="prp21059-li-0043">TdP</dt>
<dd id="prp21059-li-0044"><p>Torsade de Pointes</p></dd>
<dt id="prp21059-li-0045">TQT</dt>
<dd id="prp21059-li-0046"><p>Thorough QT</p></dd>
<dt id="prp21059-li-0047">UA</dt>
<dd id="prp21059-li-0048"><p>upstroke amplitude</p></dd>
<dt id="prp21059-li-0049">
<em>V</em>
<sub>peak</sub>
</dt>
<dd id="prp21059-li-0050"><p>peak voltage</p></dd>
</dl>
<section id="prp21059-sec-0001"><h2 class="pmc_sec_title">1. INTRODUCTION</h2>
<p>The ICH S7B nonclinical guideline,<a href="#prp21059-bib-0001" class="usa-link" aria-describedby="prp21059-bib-0001">
<sup>1</sup>
</a> first published in 2005 and recently revised through a Q&amp;A process,<a href="#prp21059-bib-0002" class="usa-link" aria-describedby="prp21059-bib-0002">
<sup>2</sup>
</a> aims at assessing QT prolongation and proarrhythmic potential of new pharmaceuticals before first‐in‐human dosing. The two core assays of this guidance are an in vitro hERG assay and an in vivo QT assay, generally conducted in the dog. Follow‐up in silico and in vitro proarrhythmia assays, as initially described in the Comprehensive in vitro Proarrhythmia Assay (CiPA) paradigm,<a href="#prp21059-bib-0003" class="usa-link" aria-describedby="prp21059-bib-0003">
<sup>3</sup>
</a>, <a href="#prp21059-bib-0004" class="usa-link" aria-describedby="prp21059-bib-0004">
<sup>4</sup>
</a> can also be integrated in the assessment (Figure <a href="#prp21059-fig-0001" class="usa-link">1</a>). Since Levetiracetam (LEV, Keppra®), an anti‐seizure medication (ASM) approved in many countries as monotherapy or adjunctive treatment of seizures in pediatric and adult patients, was first launched in 2000, before the introduction of the original ICH S7B guidance and CiPA approach, nonclinical cardiovascular safety data were limited to studies in dog Purkinje fibers and in anesthetized and conscious dogs. A Thorough QT (TQT) study was also conducted in healthy volunteers at therapeutic and supratherapeutic doses,<a href="#prp21059-bib-0005" class="usa-link" aria-describedby="prp21059-bib-0005">
<sup>5</sup>
</a> in compliance with the ICH E14 clinical guidance.<a href="#prp21059-bib-0006" class="usa-link" aria-describedby="prp21059-bib-0006">
<sup>6</sup>
</a> At the time of the submission, neither available nonclinical data nor the TQT assessment revealed any risk of QT prolongation and Torsade de Pointes (TdP). However, until now, the direct effects of LEV on hERG‐mediated I<sub>Kr</sub> current and other cardiac ion currents remained unknown. Therefore, the goal of this work was to “pressure test” the CiPA paradigm with a “real‐life” well‐established ASM such as LEV and check the concordance of the whole nonclinical dataset with clinical and postmarketing data. The three nonclinical components of CiPA were used: standardized in vitro cardiac ion channel patch clamp assays, in silico modeling of the human ventricular action potential, and electrophysiology and contractility measurements in human induced pluripotent stem cell‐derived cardiomyocytes (hiPSC‐CM). In addition to the CiPA and S7B‐related assays, LEV was also tested on hERG trafficking, which can, if inhibited, trigger QT prolongation after chronic treatment.<a href="#prp21059-bib-0007" class="usa-link" aria-describedby="prp21059-bib-0007">
<sup>7</sup>
</a> As they were never published so far, the nonclinical in vitro and in vivo data previously collected in dogs are presented alongside the newly generated data to establish a comprehensive integrated cardiovascular safety risk assessment of LEV.</p>
<figure class="fig xbox font-sm" id="prp21059-fig-0001"><h3 class="obj_head">FIGURE 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2af6/9903303/44f0ff9ca94a/PRP2-11-e01059-g002.jpg" loading="lazy" id="jats-graphic-3" height="400" width="709" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/prp21059-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic representation of core and follow‐up assays of the ICH S7B nonclinical guidance and nonclinical components of the Comprehensive in Vitro Proarrhythmia Assays (CiPA) approach (adapted from ICH E14/S7B Q&amp;A training material and FDA Impact Story (<a href="https://www.fda.gov/drugs/regulatory-science-action/impact-story-improved-assessment-cardiotoxic-risk-drug-candidates-comprehensive-vitro-proarrhythmia" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Impact Story: Improved Assessment of Cardiotoxic Risk in Drug Candidates: The Comprehensive in vitro Proarrhythmia Assay | FDA</a>
</p></figcaption></figure></section><section id="prp21059-sec-0002"><h2 class="pmc_sec_title">2. 
MATERIALS AND METHODS
</h2>
<section id="prp21059-sec-0003"><h3 class="pmc_sec_title">2.1. Cardiac ion currents in patch clamp assays</h3>
<p>Chinese hamster ovary (CHO) cells stably transfected with hERG, Na<sub>V</sub>1.5, Ca<sub>V</sub>1.2 (co‐expressed with β2/α2δ1), K<sub>V</sub>1.5, K<sub>V</sub>4.3 (co‐expressed with KChiP2.2), or K<sub>ir</sub>2.1 were cultured in Ham's medium with L‐glutamine, while HEK293 cells stably expressing HCN4 or K<sub>V</sub>7.1 (co‐expressed with mink) were cultured in DMEM with L‐glutamine. All cell lines were stably transfected with cDNA encoding for the human isoform of the different tested ion channels. Transfection was performed by lipofection, and integration of the genes into the host cell's genome was proven by PCR. All media were supplemented with 10% FBS and 1% Penicillin/Streptomycin at 37°C, 5% CO<sub>2</sub>, and saturated humidity. Shortly before experimentation, the cells were harvested with Detachin™ 2–3 days after plating at a confluence of about 70% and resuspended in PBS. Except for hERG assay which was conducted under GLP conditions at near physiological temperature (35–37°C),<a href="#prp21059-bib-0008" class="usa-link" aria-describedby="prp21059-bib-0008">
<sup>8</sup>
</a> all other experiments were performed under non‐GLP at room temperature. Manual patch clamp using EPC‐10 (HEKA Elektronik GmbH) was used for hERG and K<sub>V</sub>7.1/mink, while for the other channels, automated patch clamp using QPatch 16X or HTX (Sophion Bioscience) was used.</p>
<p>The composition of extracellular and intracellular solutions, the voltage protocols, as well as the positive controls used for each current assay are described in the <a href="#prp21059-supitem-0001" class="usa-link">Supplementary Methods</a>. LEV was supplied by UCB Pharma S.A. and directly dissolved in bath solution to obtain four test concentrations of 0.25, 0.75, 2.5, and 7.5 mM, corresponding to 1, 3, 10, and 30‐fold the free therapeutic plasma concentration (FTPC) in man. Analysis of variance (ANOVA) followed by multi‐sample comparison (Dunnett's test) was conducted to compare LEV effects versus vehicle. In the hERG GLP assay, samples of formulations collected from the reservoir tube after preparation, as well as samples collected from the recording chamber at the end of the experiment were analyzed for LEV concentration determination using a HPLC/UV analytical method.</p>
<p>The hERG trafficking assay was similar to the “acute” hERG assay, except that it was an automated patch clamp conducted in non‐GLP conditions, at room temperature, and that cells were incubated with LEV for 24 to 28 h. A preliminary washout experiment was conducted prior to the trafficking experiment to check the reversibility of the direct hERG current block. For this, the top concentration of LEV (7.5 mM) was first applied on the cells, followed by at least 10 min of bath solution (without LEV) as washout. The same voltage protocol as for the acute hERG was applied before and after washout and tail current amplitude was measured, as well as in the trafficking experiment, at the end of the 24–28 h of incubation.</p></section><section id="prp21059-sec-0004"><h3 class="pmc_sec_title">2.2. In silico human adult cardiomyocyte electrophysiology modeling</h3>
<p>In silico human adult cardiomyocyte electrophysiology modeling was performed using the software Virtual Assay® (v.3.2 © 2018 Oxford University Innovation Ltd.), similar to previous works demonstrating high accuracy of predictions for drug‐induced proarrhythmia.<a href="#prp21059-bib-0009" class="usa-link" aria-describedby="prp21059-bib-0009">
<sup>9</sup>
</a>, <a href="#prp21059-bib-0010" class="usa-link" aria-describedby="prp21059-bib-0010">
<sup>10</sup>
</a>, <a href="#prp21059-bib-0011" class="usa-link" aria-describedby="prp21059-bib-0011">
<sup>11</sup>
</a>, <a href="#prp21059-bib-0012" class="usa-link" aria-describedby="prp21059-bib-0012">
<sup>12</sup>
</a> Simulations of action potential (AP) and calcium transient (CT) were performed using the ToR‐ORd model,<a href="#prp21059-bib-0013" class="usa-link" aria-describedby="prp21059-bib-0013">
<sup>13</sup>
</a> which is the most updated human ventricular cardiomyocytes model available in the literature. Simulations were repeated with two older models, that is, ORd<a href="#prp21059-bib-0014" class="usa-link" aria-describedby="prp21059-bib-0014">
<sup>14</sup>
</a> and ORd2‐CiPA,<a href="#prp21059-bib-0015" class="usa-link" aria-describedby="prp21059-bib-0015">
<sup>15</sup>
</a> to verify that the results are not dependent on the model choice. Three populations of virtual cardiomyocyte models were constructed, by randomly varying the main ionic current conductances, using the population of models methodology<a href="#prp21059-bib-0016" class="usa-link" aria-describedby="prp21059-bib-0016">
<sup>16</sup>
</a>, <a href="#prp21059-bib-0017" class="usa-link" aria-describedby="prp21059-bib-0017">
<sup>17</sup>
</a>:
</p>
<ol id="prp21059-list-0001" class="list" style="list-style-type:lower-roman">
<li id="prp21059-li-0051"><p>Control, with conductances varying [50–150]% of their baseline values. This population represents a healthy control.</p></li>
<li id="prp21059-li-0052"><p>Large‐variability, with conductances varying [30–200]% of their baseline values. This population includes cells with large up/down regulations of ion channels, which could be compatible with underlying conditions or genetic mutations.</p></li>
<li id="prp21059-li-0053"><p>High‐risk: conductances varied as in.<a href="#prp21059-bib-0009" class="usa-link" aria-describedby="prp21059-bib-0009">
<sup>9</sup>
</a> This population has been specifically designed with a low repolarization reserve, to maximize the risk to develop drug‐induced early‐after‐depolarizations (EADs), associated with proarrhythmic risk.</p></li>
</ol>
<p>The three populations were paced at 1 Hz for 500 beats to reach a steady state, and then calibrated using experimental AP and CT biomarkers from nondiseased human hearts.<a href="#prp21059-bib-0010" class="usa-link" aria-describedby="prp21059-bib-0010">
<sup>10</sup>
</a> Only the virtual cells displaying biomarker values within the experimental variability ranges were included in the final populations. Populations were designed to have approximately 300 cells each after calibration (control: 270; large‐variability: 283; high‐risk: 322, for a total of 875 cells).</p>
<p>To verify that our results are not dependent on the random sampling of the ionic conductances, simulations were repeated twice, using two different sets of cell populations (results shown in the Table <a href="#prp21059-supitem-0002" class="usa-link">S1</a>).</p>
<p>Simulations of LEV were performed at multiple concentrations (0.25, 0.75, 2.5, and 7.5 mM) using the data generated in the patch clamp assays as input of a simple pore‐block model<a href="#prp21059-bib-0018" class="usa-link" aria-describedby="prp21059-bib-0018">
<sup>18</sup>
</a> for the different ion channels. Since no IC<sub>50</sub> was obtained due to very weak inhibitory activity of LEV on the different currents, we considered the actual % of current block observed at each tested concentration (Table <a href="#prp21059-tbl-0001" class="usa-link">1</a>) to scale the conductance of the different ion channels.</p>
<section class="tw xbox font-sm" id="prp21059-tbl-0001"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Effects of LEV on cardiac ion currents in patch clamp assays.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1"></th>
<th align="left" valign="bottom" rowspan="1" colspan="1">LEV 0.25 mM</th>
<th align="left" valign="bottom" rowspan="1" colspan="1">LEV 0.75 mM</th>
<th align="left" valign="bottom" rowspan="1" colspan="1">LEV 2.5 mM</th>
<th align="left" valign="bottom" rowspan="1" colspan="1">LEV 7.5 mM</th>
<th align="left" valign="bottom" rowspan="1" colspan="1">Vehicle control</th>
<th align="left" valign="bottom" rowspan="1" colspan="1">Positive control</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">hERG</td>
<td align="center" valign="top" rowspan="1" colspan="1">98.51 ± 1.71 (<em>n</em> = 6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">94.09 ± 2.25 (<em>n</em> = 6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">92.11 ± 1.60 (<em>n</em> = 6)</td>
<td align="left" valign="top" rowspan="1" colspan="1">89.10 ± 1.22<a href="#prp21059-note-0003" class="usa-link"><sup>*</sup></a> (<em>n</em> = 6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">98.44 ± 2.17 (<em>n</em> = 3)</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>17.05 ± 2.22<a href="#prp21059-note-0003" class="usa-link"><sup>*</sup></a> (<em>n</em> = 3)</p>
<p>(E‐4031 0.1 μM)</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">hERG trafficking, current density</td>
<td align="center" valign="top" rowspan="1" colspan="1">100.91 ± 6.39 (<em>n</em> = 11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">97.45 ± 4.72 (<em>n</em> = 10)</td>
<td align="center" valign="top" rowspan="1" colspan="1">102.86 ± 4.50 (<em>n</em> = 10)</td>
<td align="left" valign="top" rowspan="1" colspan="1">95.05 ± 6.10 (<em>n</em> = 10)</td>
<td align="center" valign="top" rowspan="1" colspan="1">97.94 ± 1.22 (<em>n</em> = 3)</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>−4.00 ± 1.18 (<em>n</em> = 10)</p>
<p>(pentamidine 100 μM)</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Na<sub>V</sub>1.5 fast inactivated state, peak current</td>
<td align="center" valign="top" rowspan="1" colspan="1">88.70 ± 0.41 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">81.45 ± 1.43 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">76.77 ± 0.88 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">70.22 ± 3.34 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">79.87 ± 9.32 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>12.25 ± 2.35<a href="#prp21059-note-0003" class="usa-link"><sup>*</sup></a> (<em>n</em> = 2)</p>
<p>(propafenone 10 μM)</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Na<sub>V</sub>1.5 slow inactivated state, peak current</td>
<td align="center" valign="top" rowspan="1" colspan="1">94.05 ± 0.43 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">92.68 ± 1.82 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">91.09 ± 2.67 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">86.15 ± 6.14 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">90.82 ± 9.91 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>6.23 ± 4.80<a href="#prp21059-note-0003" class="usa-link"><sup>*</sup></a> (<em>n</em> = 2)</p>
<p>(propafenone 10 μM)</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Na<sub>V</sub>1.5 resting state (1st pulse), peak current</td>
<td align="center" valign="top" rowspan="1" colspan="1">98.08 ± 2.07 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">94.87 ± 2.92 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">92.13 ± 5.44 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">87.47 ± 7.92 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">90.58 ± 11.53 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>82.73 ± 10.64 (<em>n</em> = 2)</p>
<p>(propafenone 10 μM)</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Na<sub>V</sub>1.5 resting state (last pulse), peak current</td>
<td align="center" valign="top" rowspan="1" colspan="1">97.27 ± 1.87 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">94.53 ± 2.89 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">91.73 ± 4.20 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">86.42 ± 7.20 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">91.60 ± 11.09 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>46.63 ± 11.70<a href="#prp21059-note-0003" class="usa-link"><sup>*</sup></a> (<em>n</em> = 2)</p>
<p>(propafenone 10 μM)</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Na<sub>V</sub>1.5 inactivated state, integral</td>
<td align="center" valign="top" rowspan="1" colspan="1">86.12 ± 5.13 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">85.05 ± 6.60 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">81.85 ± 8.98 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">78.71 ± 5.11 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">86.89 ± 15.65 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>7.63 ± 2.10<a href="#prp21059-note-0003" class="usa-link"><sup>*</sup></a> (<em>n</em> = 2)</p>
<p>(propafenone 10 μM)</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Na<sub>V</sub>1.5 slow inactivated state, integral</td>
<td align="center" valign="top" rowspan="1" colspan="1">94.17 ± 0.02 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">94.30 ± 2.04 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">94.85 ± 1.62 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">89.40 ± 1.32 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">97.56 ± 9.63 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>2.67 ± 2.06<a href="#prp21059-note-0003" class="usa-link"><sup>*</sup></a> (<em>n</em> = 2)</p>
<p>(propafenone 10 μM)</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Na<sub>V</sub>1.5 resting state, integral</td>
<td align="center" valign="top" rowspan="1" colspan="1">103.66 ± 5.38 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">102.63 ± 0.85 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">100.47 ± 1.84 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">98.36 ± 0.65 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">101.97 ± 4.85 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">63.35 ± 4.01 (<em>n</em> = 2) (propafenone 10 μM)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Ca<sub>V</sub>1.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">106.00 ± 5.41 (<em>n</em> = 3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">99.34 ± 4.10 (<em>n</em> = 3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">102.06 ± 1.44 (<em>n</em> = 3)</td>
<td align="left" valign="top" rowspan="1" colspan="1">99.29 ± 2.17 (<em>n</em> = 3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">80.09 ± 8.87 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>8.20 ± 7.54 <a href="#prp21059-note-0003" class="usa-link"><sup>*</sup></a> (<em>n</em> = 2)</p>
<p>(nifedipine 1 μM)</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">K<sub>V</sub>4.3, peak current</td>
<td align="center" valign="top" rowspan="1" colspan="1">99.93 ± 3.29 (<em>n</em> = 3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">98.80 ± 4.83 (<em>n</em> = 3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">97.85 ± 6.57 (<em>n</em> = 3)</td>
<td align="left" valign="top" rowspan="1" colspan="1">96.66 ± 7.89 (<em>n</em> = 3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">89.99 ± 4.69 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>25.01 ± 3.74<a href="#prp21059-note-0003" class="usa-link"><sup>*</sup></a> (<em>n</em> = 2)</p>
<p>(dapoxetine 30 μM)</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">K<sub>V</sub>4.3, integral</td>
<td align="center" valign="top" rowspan="1" colspan="1">99.71 ± 2.30 (<em>n</em> = 3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">94.56 ± 1.94 (<em>n</em> = 3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">89.93 ± 3.67 (<em>n</em> = 3)</td>
<td align="left" valign="top" rowspan="1" colspan="1">86.09 ± 5.91 (<em>n</em> = 3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">83.86 ± 5.57 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>11.45 ± 8.22<a href="#prp21059-note-0003" class="usa-link"><sup>*</sup></a> (<em>n</em> = 2)</p>
<p>(dapoxetine 30 μM)</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">K<sub>V</sub>1.5, peak current</td>
<td align="center" valign="top" rowspan="1" colspan="1">99.65 ± 2.66 (<em>n</em> = 3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">97.31 ± 2.97 (<em>n</em> = 3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">94.60 ± 6.36 (<em>n</em> = 3)</td>
<td align="left" valign="top" rowspan="1" colspan="1">88.71 ± 10.38 (<em>n</em> = 3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">91.26 ± 3.29 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>47.81 ± 5.81<a href="#prp21059-note-0003" class="usa-link"><sup>*</sup></a> (<em>n</em> = 2)</p>
<p>(S9948 10 μM)</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">K<sub>V</sub>1.5, steady state</td>
<td align="center" valign="top" rowspan="1" colspan="1">101.07 ± 3.07 (<em>n</em> = 3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">99.35 ± 3.28 (<em>n</em> = 3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">98.31 ± 3.97 (<em>n</em> = 3)</td>
<td align="left" valign="top" rowspan="1" colspan="1">92.85 ± 11.28 (<em>n</em> = 3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">86.67 ± 7.05 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>10.80 ± 3.75<a href="#prp21059-note-0003" class="usa-link"><sup>*</sup></a> (<em>n</em> = 2)</p>
<p>(S9948 10 μM)</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">K<sub>V</sub>7.1/mink, steady state</td>
<td align="center" valign="top" rowspan="1" colspan="1">105.52 ± 1.08 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">107.84 ± 3.71 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">103.39 ± 1.74 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">94.18 ± 12.71<a href="#prp21059-note-0003" class="usa-link"><sup>*</sup></a> (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">102.23 ± 2.80 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>17.91 ± 3.38<a href="#prp21059-note-0003" class="usa-link"><sup>*</sup></a> (<em>n</em> = 2)</p>
<p>(JNJ303 1 μM)</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Kir1.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">98.07 ± 3.01 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">96.56 ± 1.27 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">94.09 ± 1.33 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">90.06 ± 1.02 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">98.41 ± 6.07 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">
<p>12.20 ± 7.61<a href="#prp21059-note-0003" class="usa-link"><sup>*</sup></a> (<em>n</em> = 2)</p>
<p>(ML133 10 μM)</p>
</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">HCN4, steady state</td>
<td align="center" valign="top" rowspan="1" colspan="1">102.68 ± 2.32 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">103.37 ± 0.06 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">101.70 ± 1.32 (<em>n</em> = 2)</td>
<td align="left" valign="top" rowspan="1" colspan="1">100.91 ± 2.31 (<em>n</em> = 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">104.31 ± 4.79 (<em>n</em> = 3)</td>
<td align="left" valign="top" rowspan="1" colspan="1">29.59 ± 3.31<a href="#prp21059-note-0003" class="usa-link"><sup>*</sup></a> (<em>n</em> = 2)(ivabradine 10 μM)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/prp21059-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="prp21059-note-0002"><p>
<em>Note</em>: Results are expressed as % remaining current amplitude (mean ± SD), the number of cells tested is indicated in brackets.</p></div>
<div class="fn" id="prp21059-note-0003">
<sup>*</sup><p class="display-inline">Statistically different from the vehicle (bath solution), <em>p</em> &lt; .05 (Dunnett's test for multiple comparison).</p>
</div>
</div></section><p>Multiple drug simulation protocols were considered, to reproduce specific risk factors:
</p>
<ol id="prp21059-list-0002" class="list" style="list-style-type:lower-roman">
<li id="prp21059-li-0054"><p>Normal pacing (50 beats at 1 Hz)</p></li>
<li id="prp21059-li-0055"><p>Slow pacing (50 beats at 0.2 Hz)</p></li>
<li id="prp21059-li-0056"><p>Slow pacing (50 beats at 0.2 Hz) plus β‐adrenergic stimulation (β‐AS), which was simulated as a simple twofold increase in the conductances of the slow delayed rectifier potassium current (G<sub>Ks</sub>) and the L‐type calcium current (G<sub>CaL</sub>).</p></li>
</ol>
<p>The last beat in each simulation was analyzed, to compute the following biomarkers: AP duration at 40% and 90% of repolarization (APD<sub>40</sub> and APD<sub>90</sub>); AP triangulation, defined as the difference between APD<sub>90</sub> and APD<sub>40</sub> (Tri<sub>90‐40</sub>); maximum upstroke velocity (dV/dt<sub>MAX</sub>); peak voltage (V<sub>peak</sub>); resting membrane potential (RMP); CT duration at 90% of repolarization (CTD<sub>90</sub>); CT peak (CT<sub>peak</sub>); electromechanical window (EMw), defined as the difference between APD<sub>90</sub> and CTD<sub>90</sub>. AP traces displaying a positive derivative after 150 ms were classified as EADs.</p>
<p>Based on previous studies, we considered the following markers of proarrhythmia: (i) occurrence of EAD in the in silico population at any tested concentration;<a href="#prp21059-bib-0009" class="usa-link" aria-describedby="prp21059-bib-0009">
<sup>9</sup>
</a> (ii) more than 10% shortening of the EMw at 10‐fold FTPC.<a href="#prp21059-bib-0010" class="usa-link" aria-describedby="prp21059-bib-0010">
<sup>10</sup>
</a>
</p></section><section id="prp21059-sec-0005"><h3 class="pmc_sec_title">2.3. Human induced pluripotent stem cell‐derived cardiomyocytes (hiPSC‐CM) function</h3>
<p>Experiments on hiPSC‐CM were adapted from a protocol previously described.<a href="#prp21059-bib-0012" class="usa-link" aria-describedby="prp21059-bib-0012">
<sup>12</sup>
</a> E‐Plates for the xCELLigence RTCA CardioECR (Agilent) were coated using 10 μg/mL bovine fibronectin (Sigma Aldrich) dissolved in PBS (Thermofisher/Gibco 14 040‐083 DPBS). Cells (iCell<sup>2</sup>® Cardiomyocytes, FujiFilm CDI) were thawed and seeded at the density 50 000/well in iCell Plating Medium (FujiFilm CDI) according to the manufacturer's recommendations. From 4 h of postplating, cardiomyocytes were maintained on the E‐Plates in the Maintenance Medium (FujiFilm CDI) which was replaced every 48 h. Four to 5 days after plating, the cells were incubated for 24 h with LEV at 0.25, 0.75, 2.5, and 7.5 mM. Nifedipine (100 and 300 nM), dofetilide (10 and 20 nM), and E‐4031 (30 and 50 nM) were used as positive, and 0.1% DMSO as negative controls. Impedance data, that is, Cell Index (CI), beat rate, and CI amplitude, as well as ECR (Extracellular Recording) data, that is, sodium spike amplitude and field potential duration (FPD) were recorded by RTCA CardioECR at baseline, 30 min, 1, 6, 12, and 24‐h posttreatment. These data were normalized to baseline and vehicle for matching time points. FPD was corrected for heart rate using Fridericia's formula. Intergroup comparisons were made using first a two‐way (treatment, time) ANOVA followed by an unpaired Student's <em>t</em> test when the ANOVA was significant (<em>p</em> &lt; .05). No statistical analysis was conducted for the sodium spike amplitude due to the high variability of this parameter.</p></section><section id="prp21059-sec-0006"><h3 class="pmc_sec_title">2.4. Action potential recordings in dog Purkinje fibers</h3>
<p>Left ventricular cardiac Purkinje fibers, isolated from female Beagle dogs, were maintained in vitro by perfusion with physiological salt solution at 35–36°C. The fibers were impaled with 3 M KCl‐filled glass microelectrodes and electrically stimulated at 1, 0.5, and 3 Hz to monitor the evoked cardiac action potential. The following parameters were measured: APD<sub>60</sub> and APD<sub>90</sub>, maximum rate of depolarization (MRD), upstroke amplitude (UA), and resting membrane potential (RMP). The effects of increasing concentrations of LEV (0.59, 1.76, and 5.9 mM, approximately 30 min at each concentration) or vehicle (0.1%, 0.3%, and 1% sterile water, respectively) were each investigated in four fibers. At each concentration of LEV or corresponding vehicle, the AP parameters were recorded at stimulation frequencies of 1 and 0.5 Hz. After incubation with 5.9 mM LEV (or corresponding vehicle), the AP parameters were recorded at 3 Hz. At the end of the experiment, the vehicle‐treated fibers were exposed for 30 min to dl‐sotalol hydrochloride (50 μM) to confirm sensitivity of the test system to an agent with AP prolonging activity. Changes from baseline values for each parameter in each group were compared using the Mann–Whitney U‐test or unpaired two‐tailed Student's <em>t</em>‐test, when the homogeneity of variance was rejected or accepted, respectively (F‐statistic, significance level of 0.05).</p></section><section id="prp21059-sec-0007"><h3 class="pmc_sec_title">2.5. Electrocardiography and hemodynamics in conscious telemetered dogs</h3>
<p>The experiments were conducted under GLP conditions, were reviewed by the institutional ethics committee, and approved by the French Ministry of Research, in compliance with animal welfare legislation in force at the time of the study completion (Directive 86/609/EEC). After a minimum of 1 week of acclimation, male and female Beagle dogs (<em>n</em> = 3/sex, 8–23 months old) were instrumented with an RLA2000 telemetry transmitter (DataSciences Inc.) placed in the abdominal cavity and the pressure catheter into the femoral artery, under thiopental (20 mg/kg i.v.) and halothane (1–1.5%) anesthesia. ECG electrodes were placed in Lead II position and waveforms were recorded using the ART™ acquisition system (DataSciences Inc.). After 18–24 days of postsurgical recovery, each dog was dosed successively with 0 (control), 150, 300, and 600 mg/kg LEV per os, with 2–3 days interval between each treatment. Food was distributed 6 h after dosing. Telemetric measurements of arterial blood pressure (mean, systolic, and diastolic), heart rate, and ECG were recorded 24 h before the first administration and continued over 24 h after each treatment. In addition, six leads (I, II, III, aVR, aVL, and aVF) ECGs were collected before and 3‐h postdosing by placing animals in a sling and by using the Valentine PC‐ECG™ acquisition system (Brentwood). PR, QRS, and QT intervals were calculated, and QT was corrected for heart rate using Fridericia's formula and an individual correction based on Sarma's equation:<a href="#prp21059-bib-0019" class="usa-link" aria-describedby="prp21059-bib-0019">
<sup>19</sup>
</a>
</p>
<table class="disp-formula p" id="prp21059-disp-0001"><tr><td class="formula"><math id="jats-math-1" display="block" overflow="linebreak"><mrow><mrow><mi>QTc</mi><mo linebreak="goodbreak">=</mo><mi mathvariant="normal">a</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">x</mi><mspace width="0.25em"></mspace><msup><mi mathvariant="normal">e</mi><mi>bRR</mi></msup><mo linebreak="goodbreak">+</mo><mi mathvariant="normal">c</mi></mrow></mrow></math></td></tr></table>
<p>where a, b and c were defined by fitting of the QT/RR relationship from pairs of QT/RR values collected by telemetry in the test facility throughout 1 year from untreated control dogs (15 males and 15 females, 306 pairs of data).</p>
<p>Blood samples were collected just before and 3 h after dosing for determination of LEV plasma concentrations.</p></section><section id="prp21059-sec-0008"><h3 class="pmc_sec_title">2.6. Integrated QT risk assessment</h3>
<p>A composite plot (QT‐ogram) was constructed using free concentrations of LEV and % change in QT‐related biomarkers generated in the different models, that is, I<sub>Kr</sub> current in patch clamp assay, APD<sub>90</sub> in virtual human cardiomyocytes and dog Purkinje fibers, FPDc in hiPSC‐CM, QTc in conscious dogs, and upper bound of the 95% CI of ΔΔQTc at steady state in healthy volunteers, extracted from the TQT study.<a href="#prp21059-bib-0005" class="usa-link" aria-describedby="prp21059-bib-0005">
<sup>5</sup>
</a> FTPC was considered to be 0.25 mM for a 1500 mg dose<a href="#prp21059-bib-0020" class="usa-link" aria-describedby="prp21059-bib-0020">
<sup>20</sup>
</a> (LEV molecular weight:170.21; plasma protein binding in man: 10%).</p></section></section><section id="prp21059-sec-0009"><h2 class="pmc_sec_title">3. RESULTS</h2>
<section id="prp21059-sec-0010"><h3 class="pmc_sec_title">3.1. Cardiac ion currents in patch clamp assays</h3>
<p>In the hERG manual patch clamp assay, a slight inhibition of tail current starting from 0.75 mM LEV (4% vs. vehicle control, not significant) and reaching 9% versus vehicle control at 7.5 mM (<em>p</em> &lt; .05) was noted. A typical current trace of a control cell and a cell treated with LEV is shown in Figure <a href="#prp21059-fig-0002" class="usa-link">2A</a>. The analysis of dose formulations and bath solutions samples demonstrated the absence of adsorption on the material (recovery between 99% and 110%). As tail currents were inhibited by less than 30% at the highest concentration, no concentration‐response curve was constructed and no IC<sub>50</sub> was calculated.</p>
<figure class="fig xbox font-sm" id="prp21059-fig-0002"><h4 class="obj_head">FIGURE 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2af6/9903303/ee0a63044e17/PRP2-11-e01059-g005.jpg" loading="lazy" id="jats-graphic-5" height="548" width="709" alt="FIGURE 2"></p>
<div class="p text-right font-secondary"><a href="figure/prp21059-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Panel A: Representative I<sub>Kr</sub> current traces in the acute hERG assay (left) and the hERG trafficking assay (right) (black: control; red: 7.5 mM LEV); Panel B: concentration‐response curve of I<sub>Kr</sub> current in the acute hERG assay (mean and standard error of the mean (SEM), <em>n</em> = 4) and the hERG trafficking assay (mean and SEM, <em>n</em> = 10).</p></figcaption></figure><p>LEV did not significantly inhibit the other cardiac ion currents, except K<sub>V</sub>7.1/mink‐mediated current which was reduced by 8% versus vehicle control at 7.5 mM (<em>p</em> &lt; .05; Table <a href="#prp21059-tbl-0001" class="usa-link">1</a>). All positive controls exhibited their expected effects.</p>
<p>In the hERG trafficking assay, all LEV concentrations produced &lt;5% inhibition of tail current after 24‐h incubation, indicating the absence of effects on trafficking (Figure <a href="#prp21059-fig-0002" class="usa-link">2B</a>).</p></section><section id="prp21059-sec-0011"><h3 class="pmc_sec_title">3.2. In silico human adult cardiomyocyte electrophysiology modeling</h3>
<p>Based on the patch clamp assays, we scaled the following ion channel conductances in the in silico human cardiomyocyte models to reproduce the effect of LEV: 0.25 mM (1x FTPC), G<sub>Kr</sub> 98.51%; 0.75 mM (3x FTPC), G<sub>Kr</sub> 94.09%; 2.5 mM (10x FTPC), G<sub>Kr</sub> 92.11%; 7.5 mM (30x FTPC), G<sub>Kr</sub> 89.10%, and G<sub>Ks</sub> 94.18%. This corresponds to the worst‐case scenario, that is, we considered the maximum inhibition of G<sub>Kr</sub> and G<sub>Ks</sub> observed at each concentration, even when not statistically significant.</p>
<p>Very small changes were observed in AP and CT biomarkers for up to 7.5 mM LEV in the three populations of virtual human cells (control, large‐variability, or high‐risk), compared with control conditions (no drug), at normal pacing (1 Hz). Table <a href="#prp21059-tbl-0002" class="usa-link">2</a> shows the median percentage changes measured for all tested LEV concentrations. Most biomarker changes remained far below 5%, with the largest variations observed at the highest tested concentration for APD, Tri<sub>90‐40</sub>, CT<sub>peak</sub>, and EMw.</p>
<section class="tw xbox font-sm" id="prp21059-tbl-0002"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>Effects of LEV on a selection of biomarkers in normal, large‐variability and high‐risk populations of virtual human adult cardiomyocytes (Virtual Assay), in real human induced pluripotent stem cell‐derived (hiPSC)‐cardiomyocytes (RTCA‐ECR Cardio platform), and in dog Purkinje fibers.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="2" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1"></th>
<th align="left" colspan="4" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Virtual human adult cardiomyocytes<a href="#prp21059-note-0005" class="usa-link">
<sup>a</sup>
</a>
</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">LEV 0.25 mM</th>
<th align="left" valign="bottom" rowspan="1" colspan="1">LEV 0.75 mM</th>
<th align="left" valign="bottom" rowspan="1" colspan="1">LEV 2.5 mM</th>
<th align="left" valign="bottom" rowspan="1" colspan="1">LEV 7.5 mM</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">APD<sub>90</sub>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.8 /0.7/0.8%</td>
<td align="left" valign="top" rowspan="1" colspan="1">3.1/3.0/3.1%</td>
<td align="left" valign="top" rowspan="1" colspan="1">4.1/3.4/4.2%</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.8/6.2/5.8%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">APD<sub>40</sub>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">−0.3/0.5/0.5%</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.8/2.4/2.2%</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.4/3.2/3.0%</td>
<td align="left" valign="top" rowspan="1" colspan="1">3.8/5.2/3.8%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Tri<sub>90‐40</sub>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.1/0.4/1.4%</td>
<td align="left" valign="top" rowspan="1" colspan="1">4.4/5.0/5.0%</td>
<td align="left" valign="top" rowspan="1" colspan="1">5.9/6.6/6.5%</td>
<td align="left" valign="top" rowspan="1" colspan="1">8.8/9.6/9.1%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">RMP</td>
<td align="left" valign="top" rowspan="1" colspan="1">&lt;0.5%</td>
<td align="left" valign="top" rowspan="1" colspan="1">&lt;0.5%</td>
<td align="left" valign="top" rowspan="1" colspan="1">&lt;0.5%</td>
<td align="left" valign="top" rowspan="1" colspan="1">&lt;0.5%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">V<sub>peak</sub>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">&lt;0.5%</td>
<td align="left" valign="top" rowspan="1" colspan="1">&lt;0.5%</td>
<td align="left" valign="top" rowspan="1" colspan="1">&lt;0.5%</td>
<td align="left" valign="top" rowspan="1" colspan="1">&lt;0.5%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">dV/dt<sub>MAX</sub>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">&lt;0.5%</td>
<td align="left" valign="top" rowspan="1" colspan="1">&lt;0.5%</td>
<td align="left" valign="top" rowspan="1" colspan="1">&lt;0.5%</td>
<td align="left" valign="top" rowspan="1" colspan="1">&lt;0.5%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">CTD<sub>90</sub>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">&lt;0.5%</td>
<td align="left" valign="top" rowspan="1" colspan="1">&lt;0.5%</td>
<td align="left" valign="top" rowspan="1" colspan="1">&lt;0.5%</td>
<td align="left" valign="top" rowspan="1" colspan="1">&lt;1.0%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">CT<sub>peak</sub>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.2/0.2/0.3%</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.9/1.2/0.6%</td>
<td align="left" valign="top" rowspan="1" colspan="1">3.6/1.7/1.1%</td>
<td align="left" valign="top" rowspan="1" colspan="1">6.6/3.8/1.3%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">EMw</td>
<td align="left" valign="top" rowspan="1" colspan="1">−1.3/−1.1/−1.9%</td>
<td align="left" valign="top" rowspan="1" colspan="1">−4.2/−5.2/−8.9%</td>
<td align="left" valign="top" rowspan="1" colspan="1">−6.8/−6.8/−12.2%</td>
<td align="left" valign="top" rowspan="1" colspan="1">−9.4/−9.6/−17.5%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">EAD</td>
<td align="left" valign="top" rowspan="1" colspan="1">ND</td>
<td align="left" valign="top" rowspan="1" colspan="1">ND</td>
<td align="left" valign="top" rowspan="1" colspan="1">ND</td>
<td align="left" valign="top" rowspan="1" colspan="1">ND</td>
</tr>
</tbody>
</table></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="2" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1"></th>
<th align="left" colspan="4" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">hiPSC‐cardiomyocytes<a href="#prp21059-note-0006" class="usa-link">
<sup>b</sup>
</a>
</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">LEV 0.25 mM</th>
<th align="left" valign="bottom" rowspan="1" colspan="1">LEV 0.75 mM</th>
<th align="left" valign="bottom" rowspan="1" colspan="1">LEV 2.5 mM</th>
<th align="left" valign="bottom" rowspan="1" colspan="1">LEV 7.5 mM</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Cell Index</td>
<td align="left" valign="top" rowspan="1" colspan="1">−6%(24 h)</td>
<td align="left" valign="top" rowspan="1" colspan="1">−6% (24 h)</td>
<td align="left" valign="top" rowspan="1" colspan="1">−7% (24 h)</td>
<td align="left" valign="top" rowspan="1" colspan="1">−6% (24 h)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Beating Rate</td>
<td align="left" valign="top" rowspan="1" colspan="1">5% (12 h)</td>
<td align="left" valign="top" rowspan="1" colspan="1">4% (12 h)</td>
<td align="left" valign="top" rowspan="1" colspan="1">10% (24 h)</td>
<td align="left" valign="top" rowspan="1" colspan="1">12% (24 h)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">CI Amplitude</td>
<td align="left" valign="top" rowspan="1" colspan="1">−18% (24 h)</td>
<td align="left" valign="top" rowspan="1" colspan="1">−18% (24 h)</td>
<td align="left" valign="top" rowspan="1" colspan="1">−25% (24 h)*</td>
<td align="left" valign="top" rowspan="1" colspan="1">−16% (6 h)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">FPDc</td>
<td align="left" valign="top" rowspan="1" colspan="1">−5% (24 h)</td>
<td align="left" valign="top" rowspan="1" colspan="1">−2% (24 h)</td>
<td align="left" valign="top" rowspan="1" colspan="1">−6% (24 h)</td>
<td align="left" valign="top" rowspan="1" colspan="1">−4% (24 h)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">EAD</td>
<td align="left" valign="top" rowspan="1" colspan="1">ND</td>
<td align="left" valign="top" rowspan="1" colspan="1">ND</td>
<td align="left" valign="top" rowspan="1" colspan="1">ND</td>
<td align="left" valign="top" rowspan="1" colspan="1">ND</td>
</tr>
</tbody>
</table></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="2" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1"></th>
<th align="left" colspan="4" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Dog Purkinje fibers<a href="#prp21059-note-0007" class="usa-link">
<sup>c</sup>
</a>
</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">SOTALOL 0.05 mM</th>
<th align="left" valign="bottom" rowspan="1" colspan="1">LEV 0.59 mM</th>
<th align="left" valign="bottom" rowspan="1" colspan="1">LEV 1.56 mM</th>
<th align="left" valign="bottom" rowspan="1" colspan="1">LEV 5.9 mM</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">APD<sub>90</sub>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">44.1%*/59.3%*</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.7%/5.3%</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.3%/0.3%</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.5%/2.5%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">APD<sub>60</sub>
</td>
<td align="left" valign="top" rowspan="1" colspan="1">44.7%**/58.8%*</td>
<td align="left" valign="top" rowspan="1" colspan="1">3.3%/6.6%</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.6%/−0.8%</td>
<td align="left" valign="top" rowspan="1" colspan="1">−0.4%/0.0%</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">MRD</td>
<td align="left" valign="top" rowspan="1" colspan="1">7.1%/9.3%</td>
<td align="left" valign="top" rowspan="1" colspan="1">−4.7%/−7.1%</td>
<td align="left" valign="top" rowspan="1" colspan="1">−3.1%/−1.5%</td>
<td align="left" valign="top" rowspan="1" colspan="1">−3.6%/−4.9% (−2.1%)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">UA</td>
<td align="left" valign="top" rowspan="1" colspan="1">−0.3%/−0.8%</td>
<td align="left" valign="top" rowspan="1" colspan="1">−2.6%/−3.3%</td>
<td align="left" valign="top" rowspan="1" colspan="1">−1.1%/−2.3%</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.0%/−1.0%</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/prp21059-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="prp21059-note-0004"><p>Abbreviations: APD, action potential duration at 90% (APD<sub>90</sub>), 60% (APD<sub>60</sub>), or 40% (APD<sub>40</sub>) repolarization; CI, cell index; CTD<sub>90</sub>, calcium transient duration at 90% repolarization; CT<sub>peak</sub>, calcium transient peak; dV/dt<sub>MAX</sub>, maximum upstroke velocity; EAD, early‐after depolarization; EMw, electromechanical window; FPDc, field potential duration corrected for beat rate; MRD, maximum rate of depolarization; RMP, resting membrane potential; Tri<sub>90‐40</sub>, triangulation defined as the difference between APD<sub>90</sub> and APD<sub>40</sub>; UA, upstroke amplitude; <em>V</em>
<sub>peak</sub>, peak voltage.</p></div>
<div class="fn" id="prp21059-note-0005">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Median % changes in the normal/large‐variability/high‐risk populations with LEV compared to control (no drug), when pacing at 1 Hz.</p>
</div>
<div class="fn" id="prp21059-note-0006">
<sup>
<sup>b</sup>
</sup><p class="display-inline">Maximal effects observed, expressed as double delta % changes (% baseline, corrected for vehicle); time at which the maximal effect was observed is indicated in brackets. ND: not detected. *<em>p</em>&lt;.05, in unpaired two‐tailed Student's <em>t</em> test comparing treatment versus vehicle control.</p>
</div>
<div class="fn" id="prp21059-note-0007">
<sup>
<sup>c</sup>
</sup><p class="display-inline">% changes compared to corresponding vehicle group at 1 Hz/ 0.5 Hz stimulation frequency. For MRD, the % change vs vehicle obtained at 3 Hz is also given in brackets. *<em>p</em>&lt;.05, **<em>p</em>&lt;.01, in unpaired two‐tailed Student's <em>t</em> test comparing treatment versus vehicle control.</p>
</div>
</div></section><p>APD<sub>90</sub> prolongation and EMw shortening at 10‐fold FTPC (−3.1% and −4.2%, respectively) were both below the safety thresholds defined as biologically meaningful to identify proarrhythmic risk in previous studies, i.e. ΔAPD<sub>90</sub> &gt;6%<a href="#prp21059-bib-0009" class="usa-link" aria-describedby="prp21059-bib-0009">
<sup>9</sup>
</a> and ΔEMw−10%.<a href="#prp21059-bib-0010" class="usa-link" aria-describedby="prp21059-bib-0010">
<sup>10</sup>
</a> The distribution of simulated APD<sub>90</sub> and EMw in control and with LEV for the three populations is shown in Figure <a href="#prp21059-fig-0003" class="usa-link">3</a>.</p>
<figure class="fig xbox font-sm" id="prp21059-fig-0003"><h4 class="obj_head">FIGURE 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2af6/9903303/3095e446c983/PRP2-11-e01059-g001.jpg" loading="lazy" id="jats-graphic-7" height="695" width="709" alt="FIGURE 3"></p>
<div class="p text-right font-secondary"><a href="figure/prp21059-fig-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Simulated LEV‐induced changes in action potential duration at 90% repolarisation (APD<sub>90</sub>, left) and electromechanical window (EMw, right) for control (A), large‐variability (B), and high‐risk (C) populations of virtual human adult cardiomyocytes. Results are shown for all tested concentrations, from control (no drug, 0x) to 30x the free therapeutic plasma concentration (FTPC). In each boxplot, the central mark is the median of the population, box limits are the 25th and 75th percentiles, and whiskers extend to the most extreme data points not considered outliers, which are plotted individually as separate crosses.</p></figcaption></figure><p>No EADs were observed in any of the 875 virtual cell models at 1 Hz nor at slow pacing (0.2 Hz), for LEV concentrations up to 7.5 mM. Only when including the combination of slow pacing and β‐adrenergic stimulation, both well‐known risk factors for repolarization abnormalities, a few EADs were observed. These occurred in the large‐variability population (<em>n</em> = 1 EAD at 7.5 mM) and in the high‐risk population (<em>n</em> = 2 EADs at 0.25 mM and <em>n</em> = 5 at 0.75, 2.5, and 7.5 mM). Cells displaying EADs were all characterized by low repolarization reserve, and particularly high conductance values for the Na<sup>+</sup>‐Ca<sup>2+</sup> exchanger and L‐Type Ca<sup>2+</sup> current (Figure <a href="#prp21059-fig-0004" class="usa-link">4</a>), in agreement with previous findings.<a href="#prp21059-bib-0009" class="usa-link" aria-describedby="prp21059-bib-0009">
<sup>9</sup>
</a>, <a href="#prp21059-bib-0010" class="usa-link" aria-describedby="prp21059-bib-0010">
<sup>10</sup>
</a> Results were found to be consistent across different populations and several human action potential models (Table <a href="#prp21059-supitem-0002" class="usa-link">S1</a>).</p>
<figure class="fig xbox font-sm" id="prp21059-fig-0004"><h4 class="obj_head">FIGURE 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2af6/9903303/c4eee71da163/PRP2-11-e01059-g003.jpg" loading="lazy" id="jats-graphic-9" height="562" width="709" alt="FIGURE 4"></p>
<div class="p text-right font-secondary"><a href="figure/prp21059-fig-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Simulated human ventricular action potential traces following the application of LEV (left), with models displaying early‐after depolarizations (EADs) highlighted in blue, and corresponding distribution of ionic current conductances (right), shown as scaling factors compared to their baseline values. Colored boxplots refer to the distribution in the whole population (reflecting the ranges described in the Materials and Methods section). In each boxplot, the central mark is the median of the population, box limits are the 25th and 75th percentiles, whiskers extend to the most extreme data points not considered outliers, while black squares are used to highlight the scaling factors of the models displaying EADs. Results are shown for the lowest LEV concentration inducing EADs in the maximum number of cells. (A) Large‐variability population with LEV 7.5 mM: 1 EAD out of 283 in silico human adult cardiomyocyte models. (B) High‐risk population with LEV 0.75 mM: 5 EADs out of 322 in silico human adult cardiomyocyte models.</p></figcaption></figure></section><section id="prp21059-sec-0012"><h3 class="pmc_sec_title">3.3. Human induced pluripotent stem cell‐derived cardiomyocytes (hiPSC‐CM) function</h3>
<p>Positive controls, dofetilide (10 and 20 nM) and E‐4031 (30 and 50 nM) produced EADs in hiPSC‐CM at all time points tested, which was expected for hERG blockers (data not shown). Nifedipine (300 nM) exhibited a FPDc shortening, as expected for a calcium channel blocker (data not shown). No EADs or statistically/biologically (&gt;10%) significant changes in FPDc were observed in hiPSC‐CM at any LEV concentration tested (Table <a href="#prp21059-tbl-0002" class="usa-link">2</a>). Slight decrease in contractility amplitude (max. −25% at 2.5 mM; <em>p</em> &lt; .05) was seen at 24‐h posttreatment; however, it appeared to be concentration‐independent (Table <a href="#prp21059-tbl-0002" class="usa-link">2</a>). LEV did not affect Cell Index up to 24 h post‐treatment.</p></section><section id="prp21059-sec-0013"><h3 class="pmc_sec_title">3.4. Action potential recordings in dog Purkinje fibers</h3>
<p>At stimulation frequencies of 1 and 0.5 Hz, LEV induced no statistically or biologically (i.e., &gt;10%) significant changes in any of the AP parameters compared to vehicle control (Table <a href="#prp21059-tbl-0002" class="usa-link">2</a>). When the frequency was increased from 1 to 3 Hz at the top concentration (5.9 mM), there was no significant difference between the vehicle and LEV in MRD. Sotalol induced its expected effects, that is, significant increases in APD<sub>60</sub> (45%) and APD<sub>90</sub> (44%) at 1 Hz, reaching 58–59% increase at 0.5 Hz, without any effect on other AP parameters.</p></section><section id="prp21059-sec-0014"><h3 class="pmc_sec_title">3.5. Electrocardiography and hemodynamics in conscious telemetered dogs</h3>
<p>LEV had no significant or biologically relevant effects on blood pressure, heart rate, and ECG parameters at single oral doses of 150 and 300 mg/kg. At the top dose, a transient increase in heart rate (E<sub>max</sub>: +34% vs. baseline, 1‐h postdose) and a shortening of the QT interval (E<sub>max</sub>: −11% vs. baseline, 1‐h postdose) were noted. However, after correction for heart rate, QTc interval did not show any significant increase. No changes in the other cardiovascular parameters were observed. In six lead ECGs, no morphological waveform abnormalities were recorded in any dog regardless the LEV dose. Total plasma concentrations measured 3 h of postdosing were 160 ± 15, 303 ± 34 and 507 ± 63 μg/mL (mean ± SD) at 150, 300 and 600 mg/kg, respectively, corresponding to unbound plasma concentrations of 0.85, 1.60, and 2.68 mM.</p></section><section id="prp21059-sec-0015"><h3 class="pmc_sec_title">3.6. Integrated QT risk assessment</h3>
<p>LEV composite QT‐ogram (Figure <a href="#prp21059-fig-0005" class="usa-link">5</a>) illustrates that no biologically relevant changes (&gt;10% or 10 ms) in QT‐related biomarkers occur up to at least 30‐fold the FTPC of LEV. The Cardiac Safety Index (defined as the ratio between hERG IC<sub>50</sub> and FTPC) should even be far above 30, as 7.5 mM (top concentration tested) represents approximately the IC<sub>10</sub> (concentration producing 10% inhibition of I<sub>Kr</sub> current). In the TQT study,<a href="#prp21059-bib-0005" class="usa-link" aria-describedby="prp21059-bib-0005">
<sup>5</sup>
</a> the concentration‐QTc analysis showed that the predicted ΔQTc,ss at the measured <em>C</em>
<sub>max</sub> of 1 and 5 g LEV (doses tested in the study) was 2.57 and 4.34 ms, respectively, which is below the threshold of 10 ms. The slope of the linear regression model applied to the individual data (0.017 ms/(μg/mL)) was not statistically different from zero.</p>
<figure class="fig xbox font-sm" id="prp21059-fig-0005"><h4 class="obj_head">FIGURE 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2af6/9903303/c90d50c86ecb/PRP2-11-e01059-g006.jpg" loading="lazy" id="jats-graphic-11" height="325" width="709" alt="FIGURE 5"></p>
<div class="p text-right font-secondary"><a href="figure/prp21059-fig-0005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Composite QT‐ogram plot showing the hERG/QT‐related parameters in the different models. Data are presented as % inhibition versus vehicle (hERG), % action potential duration at 90% repolarisation (APD<sub>90</sub>) change versus controls at 1 Hz (virtual human cardiomyocytes (CM) and dog Purkinje fibers), maximum % field potential duration corrected for beating rate (FPDc) change versus baseline, vehicle corrected (human induced pluripotent stem cell‐derived cardiomyocytes, hiPSC‐CM), % QTc change versus baseline (conscious dogs), and ΔΔQTc at steady‐state, upper bound of one‐sided 95% confidence interval (TQT study extracted from Hulhoven et al.<a href="#prp21059-bib-0005" class="usa-link" aria-describedby="prp21059-bib-0005">
<sup>5</sup>
</a>). FTPC: free therapeutic plasma concentration (0.25 mM at a dose of 1500 mg LEV). The horizontal dotted line corresponds to 10 msec threshold level for a negative TQT study or 10% threshold for considering effects as biologically relevant in nonclinical models.</p></figcaption></figure></section></section><section id="prp21059-sec-0016"><h2 class="pmc_sec_title">4. DISCUSSION</h2>
<p>LEV is a long‐established ASM approved in many countries as monotherapy or adjunctive treatment of seizures in pediatric and adult patients. It binds synaptic vesicle protein SV2A.<a href="#prp21059-bib-0021" class="usa-link" aria-describedby="prp21059-bib-0021">
<sup>21</sup>
</a> Since it was launched in 2000, before the introduction of the ICH S7B guidance defining the preclinical assessment of QT prolongation risk,<a href="#prp21059-bib-0001" class="usa-link" aria-describedby="prp21059-bib-0001">
<sup>1</sup>
</a> the nonclinical cardiovascular safety pharmacology package only comprised a dog Purkinje fiber assay and several in vivo studies in dogs. A TQT study was conducted in healthy volunteers at therapeutic and supratherapeutic doses of LEV,<a href="#prp21059-bib-0005" class="usa-link" aria-describedby="prp21059-bib-0005">
<sup>5</sup>
</a> in compliance with the ICH E14 clinical guidance.<a href="#prp21059-bib-0006" class="usa-link" aria-describedby="prp21059-bib-0006">
<sup>6</sup>
</a> However, the effects of LEV on cardiac ion channels, in particular hERG, were never assessed so far.</p>
<p>In 2013, the CiPA paradigm<a href="#prp21059-bib-0003" class="usa-link" aria-describedby="prp21059-bib-0003">
<sup>3</sup>
</a>, <a href="#prp21059-bib-0004" class="usa-link" aria-describedby="prp21059-bib-0004">
<sup>4</sup>
</a> was introduced to further assess TdP risk beyond hERG and QT prolongation, using a set of three nonclinical in vitro and in silico assays. The recently adopted ICH E14/S7B Q&amp;As<a href="#prp21059-bib-0002" class="usa-link" aria-describedby="prp21059-bib-0002">
<sup>2</sup>
</a> which partly integrates CiPA assays (Figure <a href="#prp21059-fig-0001" class="usa-link">1</a>) now offers to drug makers multiple strategies to evaluate proarrhythmic risk and potentially avoid a mandatory clinical TQT study. Here, we used LEV to retrospectively test the predictivity of the CiPA assays and verify the concordance of the full nonclinical dataset with available clinical and postmarketing data.</p>
<section id="prp21059-sec-0017"><h3 class="pmc_sec_title">4.1. Minimal effects of LEV on cardiac ion currents</h3>
<p>Standardized patch clamp assays are the first of the three nonclinical CiPA assays. We tested the direct effects of LEV on a panel of eight ion channels involved in cardiac action potential, including hERG. While some currents such as Na<sub>V</sub>1.5 or Ca<sub>V</sub>1.2 can mitigate hERG blockade,<a href="#prp21059-bib-0022" class="usa-link" aria-describedby="prp21059-bib-0022">
<sup>22</sup>
</a> some other potassium currents (K<sub>V</sub>4.3, Kir2.1, K<sub>V</sub>7.1/mink) are known to be associated with QT prolongation and could therefore aggravate QT prolongation risk due to hERG block. Small inhibition of hERG‐mediated current, starting at 0.75 mM (4% vs. vehicle) and reaching 9% at 7.5 mM LEV, was noted in the GLP assay. A 5–10% hERG inhibition is generally considered biologically relevant as it can translate into a 5–10 ms increase in QT in humans for selective hERG blockers.<a href="#prp21059-bib-0023" class="usa-link" aria-describedby="prp21059-bib-0023">
<sup>23</sup>
</a> A concentration of 7.5 mM corresponds to 30‐fold the FTPC obtained after oral administration of 1500 mg LEV in healthy subjects (47.7 μg/mL total, corresponding to 0.25 mM).<a href="#prp21059-bib-0020" class="usa-link" aria-describedby="prp21059-bib-0020">
<sup>20</sup>
</a> A 30‐ to 50‐fold separation between hERG IC<sub>50</sub> and FTPC is considered as an adequate safety margin to avoid QT prolongation/TdP risk.<a href="#prp21059-bib-0024" class="usa-link" aria-describedby="prp21059-bib-0024">
<sup>24</sup>
</a>, <a href="#prp21059-bib-0025" class="usa-link" aria-describedby="prp21059-bib-0025">
<sup>25</sup>
</a> Except a minimal inhibition of K<sub>V</sub>7.1/mink‐mediated I<sub>Ks</sub> current at 7.5 mM, our patch clamp data show that LEV does not have any relevant effect on the other cardiac channels. This is corroborated by the absence of increase in PR interval (primarily Ca<sub>V</sub>1.2‐mediated) and QRS duration (primarily Na<sub>V</sub>1.5‐mediated) both in the dog telemetry study and in the clinical TQT study. Furthermore, LEV does not affect hERG trafficking, confirming the low risk of QT prolongation even after chronic treatment.</p></section><section id="prp21059-sec-0018"><h3 class="pmc_sec_title">4.2. Absence of proarrhythmic effects in different virtual human cardiomyocyte populations</h3>
<p>The second CiPA component, the in silico modeling of action potential in virtual human ventricular myocytes, revealed no relevant LEV‐induced changes in the different electrophysiology parameters compared to control conditions. EADs were not observed at normal (1 Hz) nor slow (0.2 Hz) pacing rates, and other proarrhythmic biomarkers such as APD prolongation or shortening of the electromechanical window were all below the thresholds for safety concern. This was true for all the in silico populations tested, also including high‐risk cells specifically designed with a low repolarization reserve, to maximize the chance to develop arrhythmia. Only when considering the combination of slow pacing and β‐adrenergic stimulation, both considered risk factors due to the corresponding increase of AP duration and L‐type Ca<sup>2+</sup> current, a few cells (0.7%) at 7.5 mM LEV displayed EADs. These cells were all characterized by very large conductances for the Na<sup>+</sup>‐Ca<sup>2+</sup> exchanger and L‐type Ca<sup>2+</sup> currents.</p></section><section id="prp21059-sec-0019"><h3 class="pmc_sec_title">4.3. Absence of proarrhythmic effects in dog and human in vitro action potential assays</h3>
<p>Before CiPA emerged, the dog Purkinje fiber assay was a commonly used in vitro model to assess potential proarrhythmic effects of drugs.<a href="#prp21059-bib-0026" class="usa-link" aria-describedby="prp21059-bib-0026">
<sup>26</sup>
</a> It offered the opportunity to run concentration‐response curves at different stimulation frequencies, mimicking normal heart rate, bradycardia, or tachycardia. Even in bradycardia condition (frequency of 0.5 Hz), which is known to aggravate QT prolongation and precipitate the appearance of TdP,<a href="#prp21059-bib-0027" class="usa-link" aria-describedby="prp21059-bib-0027">
<sup>27</sup>
</a> LEV did not induce any rhythm abnormalities or APD increase up to <em>ca</em> 6 mM. These results have been now confirmed by the most recent experiments on human stem cell‐derived cardiomyocytes, compliant with the third CiPA component and the proarrhythmia models recommended by the ICH S7B Q&amp;A,<a href="#prp21059-bib-0002" class="usa-link" aria-describedby="prp21059-bib-0002">
<sup>2</sup>
</a> since no significant FPDc increase and no EAD were observed after 24 h of incubation with LEV up to 7.5 mM.</p></section><section id="prp21059-sec-0020"><h3 class="pmc_sec_title">4.4. Concordance of LEV nonclinical results with clinical QT data</h3>
<p>Based on the negative results obtained in the nonclinical core and follow‐up S7B assays, if LEV was a newly developed drug, a substitute to the TQT study relying on nonclinical and Phase I ECG data could have been requested. Indeed, the favorable preclinical profile of LEV observed in the in silico and in vitro <strong>assays</strong> was confirmed by the absence of QT prolongation in the in vivo dog study. Nevertheless, a TQT study was conducted at the time of the submission, which revealed no clinically relevant change in QTc even at the supratherapeutic dose of 5000 mg.<a href="#prp21059-bib-0005" class="usa-link" aria-describedby="prp21059-bib-0005">
<sup>5</sup>
</a> Therefore, all nonclinical data are consistent together and fit with the absence of QT prolongation in healthy volunteers in the TQT study as well as in patients suffering from epilepsy in the other clinical trials conducted with LEV. Indeed, among more than 5500 patients with epilepsy who participated in randomized, double‐blind, placebo‐controlled, phase 2–4 trials, the incidence of QT prolongation was similar between placebo and LEV, with 0.16 cases per 100 patient‐years (95% CI: 0.02–1.16) in those who received placebo and 0.11 cases per 100 patient‐years in those who received LEV (95% CI: 0.02–0.79) (UCB, unpublished data).</p></section><section id="prp21059-sec-0021"><h3 class="pmc_sec_title">4.5. Very rare post‐marketing QT prolongation cases</h3>
<p>Despite the negative TQT study in healthy volunteers, very rare cases of QT prolongation have been reported in the FDA Adverse Event Report System (FAERS) database, with an estimated reporting rate of 0.56 per 100 000 patient‐years of treatment with LEV.<a href="#prp21059-bib-0028" class="usa-link" aria-describedby="prp21059-bib-0028">
<sup>28</sup>
</a> Using the background reporting in the FAERS database as a reference, QT prolongation for LEV was not considered to have a higher reporting rate than expected. Although the primary mechanism of QTc prolongation/TdP is known to be hERG blockade, many risk factors can contribute, such as KCNH2 gene mutation, electrolyte disturbances, pre‐existing heart disease, bradycardia, or gender.<a href="#prp21059-bib-0029" class="usa-link" aria-describedby="prp21059-bib-0029">
<sup>29</sup>
</a>, <a href="#prp21059-bib-0030" class="usa-link" aria-describedby="prp21059-bib-0030">
<sup>30</sup>
</a>
</p>
<p>Of interest, among published LEV cases, two patients, both females, were carrying a KCNH2 gene mutation.<a href="#prp21059-bib-0031" class="usa-link" aria-describedby="prp21059-bib-0031">
<sup>31</sup>
</a>, <a href="#prp21059-bib-0032" class="usa-link" aria-describedby="prp21059-bib-0032">
<sup>32</sup>
</a> The first one was identified as a Met645Ile point mutation. Unfortunately, UCB efforts to compare LEV inhibitory effects in mutated hERG channels and wild‐type channels were unsuccessful, since CHO cells transfected with hERG cDNA carrying the Met645Ile mutation exhibited very low current intensity (results not shown). Previous work comparing potencies of 48 compounds using wild‐type cells or cells expressing the nine most common hERG single nucleotide polymorphisms (SNP) showed that there was no trend for compounds to be consistently more or less active against a particular SNP.<a href="#prp21059-bib-0033" class="usa-link" aria-describedby="prp21059-bib-0033">
<sup>33</sup>
</a> Therefore, it is unlikely that the mutation alone would have dramatically impacted LEV hERG potency and triggered QT prolongation in this patient. Other underlying risk factors or indirect, non‐hERG mechanisms could have contributed to the QT prolongation cases in LEV‐treated patients, although with limited evidence, such as hypertension, bradycardia, concomitant use of long QT prolonging drugs, congenital heart disease, myocardial infarction, hypokalemia, renal failure and hypothyroidism. This is also reflected by the in silico simulations which showed that it is only when several risk factors such as bradycardia (slow pacing) and adrenergic stimulus are combined that some repolarization abnormalities start to be observed in a very low number of cells (&lt;1%). Some authors have also considered epilepsy as a possible interfering factor for drug‐induced QT prolongation.<a href="#prp21059-bib-0034" class="usa-link" aria-describedby="prp21059-bib-0034">
<sup>34</sup>
</a>, <a href="#prp21059-bib-0035" class="usa-link" aria-describedby="prp21059-bib-0035">
<sup>35</sup>
</a> Three potential mechanisms have been considered by which cardiac repolarization thus QT interval could be altered during seizures: increased catecholamine release,<a href="#prp21059-bib-0036" class="usa-link" aria-describedby="prp21059-bib-0036">
<sup>36</sup>
</a> alterations in respiratory pattern (hypercapnia and hypoxia can both prolong QT<a href="#prp21059-bib-0037" class="usa-link" aria-describedby="prp21059-bib-0037">
<sup>37</sup>
</a>, <a href="#prp21059-bib-0038" class="usa-link" aria-describedby="prp21059-bib-0038">
<sup>38</sup>
</a>), or cerebral damages due to ischemic strokes.<a href="#prp21059-bib-0039" class="usa-link" aria-describedby="prp21059-bib-0039">
<sup>39</sup>
</a>
</p>
<p>Despite the very low incidence of cases and the multifactorial etiology, QT prolongation was added to the LEV labeling as an adverse drug reaction in 2015 for Japan and in 2020 for European countries, to reflect that there is a reasonable possibility of rare occurrence of QT prolongation in a specific subset of patients with underlying risk factors.</p>
<p>In conclusion, this nonclinical assessment integrating core and follow‐up CiPA/S7B assays shows the absence of QT prolongation and proarrhythmic risk of LEV up to at least 10‐fold the FTPC and the good concordance of this nonclinical dataset with the clinical and post‐marketing data. However, a favorable nonclinical cardiac safety package does not fully eliminate the risk of rare cases of QT prolongation in some predisposed patients. The exact mechanism by which LEV could have resulted in prolonged QT interval in the very rare postmarketing cases remains unclear but various risk factors or indirect non‐hERG mechanisms could have contributed, on the top of minimal hERG inhibition. Overall, LEV benefit–risk balance for patients suffering from epilepsy remains largely favorable.</p></section></section><section id="prp21059-sec-0022"><h2 class="pmc_sec_title">AUTHOR CONTRIBUTIONS</h2>
<p>A.D., F‐X.M., V.G., and J‐P.V. participated to the research design and writing of the manuscript. C.K., S.H., and E.P. conducted experiments and analyzed data. M.C., F.B., J.K., A‐F.S. and B.R. contributed or reviewed the manuscript.</p></section><section id="prp21059-sec-0024"><h2 class="pmc_sec_title">FUNDING INFORMATION</h2>
<p>Blanca Rodriguez holds a Wellcome Trust Fellowship in Basic Biomedical Sciences (214 290/Z/18/Z), and an NC3Rs Infrastructure for Impact Award (NC/P001076/1). All the studies included in this work were sponsored by UCB.</p></section><section id="prp21059-sec-0025"><h2 class="pmc_sec_title">DISCLOSURE</h2>
<p>A.D., F‐X.M., M.C., V.G., F.B., J.K., A‐F.S., and J‐P.V. are employees and/or stakeholders of UCB. S.H. is employee of B'SYS GmbH.</p></section><section id="prp21059-sec-0100"><h2 class="pmc_sec_title">ETHICS STATEMENT</h2>
<p>All animal studies were carried out in compliance with European legislation on laboratory animal use and welfare in force at the time of study completion. All experimental protocols were approved by the institutional animal care and use committee.</p></section><section id="sec26"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="prp21059-supitem-0001"><div class="caption p"><p>
Appendix S1.
</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9903303/bin/PRP2-11-e01059-s002.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (53.4KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="prp21059-supitem-0002"><div class="caption p"><p>
Table S1.
</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9903303/bin/PRP2-11-e01059-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (14.3KB, docx) </sup>
</div></div></section></section><section id="prp21059-sec-0023" class="ack"><h2 class="pmc_sec_title">ACKNOWLEDGMENTS</h2>
<p>The authors wish to acknowledge Eric Martel and Nigel Gillard for their contribution to the dog studies, as well as Nancy Yuen for her valuable scientific advice.</p></section><section id="notes1"><p>

Delaunois A, Mathy F‐X, Cornet M, et al. Testing the nonclinical Comprehensive In Vitro Proarrhythmia Assay (CiPA) paradigm with an established anti‐seizure medication: Levetiracetam case study. Pharmacol Res Perspect. 2023;11:e01059. doi: 10.1002/prp2.1059

</p>
<section id="prp21059-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="prp21059-note-0001">
<p>Primary Laboratory of Origin:</p>
<p>UCB Biopharma SRL, Braine‐l'Alleud, Belgium.</p>
</div></div></section></section><section id="prp21059-sec-0027"><h2 class="pmc_sec_title">DATA AVAILABILITY STATEMENT</h2>
<p>The datasets generated for the present work are available from the corresponding author upon reasonable request.</p></section><section id="prp21059-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">REFERENCES</h2>
<section id="prp21059-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="prp21059-bib-0001">
<span class="label">1.</span><cite>
Anon
. ICH S7B: The nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. CPMP/ICH/423/02; 2005; London, <a href="http://www.emea.eu.int/pdfs/human/ich/042302en.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.emea.eu.int/pdfs/human/ich/042302en.pdf</a>.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/16237859/" class="usa-link">PubMed</a>]</li>
<li id="prp21059-bib-0002">
<span class="label">2.</span><cite>
Anon
. ICH guideline E14/S7B: clinical and nonclinical evaluation of QT/QTc interval prolongation and proarrhythmic potential‐questions and answers. EMA/CHMP/ICH/415588/2020. <a href="https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-e14/s7b-clinical-nonclinical-evaluation-qt/.Accessed" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ema.europa.eu/en/documents/scientific‐guideline/ich‐guideline‐e14/s7b‐clinical‐nonclinical‐evaluation‐qt/.Accessed</a> April 20,2022. qtc‐interval‐prolongation‐proarrhythmic‐potential‐questions‐answers‐step‐5_en.pdf</cite>
</li>
<li id="prp21059-bib-0003">
<span class="label">3.</span><cite>
Cavero I, Holzgrefe H. Comprehensive in vitro Proarrhythmia assay, a novel in vitro/in silico paradigm to detect ventricular proarrhythmic liability: a visionary 21st century initiative. Expert Opin Drug Saf. 2014;13(6):745‐758.</cite> [<a href="https://doi.org/10.1517/14740338.2014.915311" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24845945/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opin%20Drug%20Saf&amp;title=Comprehensive%20in%20vitro%20Proarrhythmia%20assay,%20a%20novel%20in%20vitro/in%20silico%20paradigm%20to%20detect%20ventricular%20proarrhythmic%20liability:%20a%20visionary%2021st%20century%20initiative&amp;author=I%20Cavero&amp;author=H%20Holzgrefe&amp;volume=13&amp;issue=6&amp;publication_year=2014&amp;pages=745-758&amp;pmid=24845945&amp;doi=10.1517/14740338.2014.915311&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0004">
<span class="label">4.</span><cite>
Gintant G, Sager PT, Stockbridge N. Evolution of strategies to improve preclinical cardiac safety testing. Nat Rev Drug Discov. 2016;15(7):457‐471.</cite> [<a href="https://doi.org/10.1038/nrd.2015.34" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26893184/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Drug%20Discov&amp;title=Evolution%20of%20strategies%20to%20improve%20preclinical%20cardiac%20safety%20testing&amp;author=G%20Gintant&amp;author=PT%20Sager&amp;author=N%20Stockbridge&amp;volume=15&amp;issue=7&amp;publication_year=2016&amp;pages=457-471&amp;pmid=26893184&amp;doi=10.1038/nrd.2015.34&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0005">
<span class="label">5.</span><cite>
Hulhoven R, Rosillon D, Bridson WE, Meeus M‐A, Salas E, Stockis A. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single‐dose, randomized, placebo‐ and active‐controlled, four‐way crossover study. Clin Therap. 2008;30(2):260‐270.</cite> [<a href="https://doi.org/10.1016/j.clinthera.2008.02.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18343264/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Therap&amp;title=Effect%20of%20levetiracetam%20on%20cardiac%20repolarization%20in%20healthy%20subjects:%20a%20single%E2%80%90dose,%20randomized,%20placebo%E2%80%90%20and%20active%E2%80%90controlled,%20four%E2%80%90way%20crossover%20study&amp;author=R%20Hulhoven&amp;author=D%20Rosillon&amp;author=WE%20Bridson&amp;author=M%E2%80%90A%20Meeus&amp;author=E%20Salas&amp;volume=30&amp;issue=2&amp;publication_year=2008&amp;pages=260-270&amp;pmid=18343264&amp;doi=10.1016/j.clinthera.2008.02.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0006">
<span class="label">6.</span><cite>
Anon
. ICH E14: The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non‐antiarrhythmic drugs. CPMP/ICH/2/04; 2005, London, <a href="http://www.emea.eu.int/pdfs/human/ich/000204en.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.emea.eu.int/pdfs/human/ich/000204en.pdf</a>.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/16237860/" class="usa-link">PubMed</a>]</li>
<li id="prp21059-bib-0007">
<span class="label">7.</span><cite>
Yeung K‐S, Meanwell NA. Inhibition of hERG channel trafficking: an under‐explored mechanism for drug‐induced QT prolongation. Chem Med Chem. 2008;3:1501‐1502. doi: 10.1002/cmdc.200800170
</cite> [<a href="https://doi.org/10.1002/cmdc.200800170" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18696522/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chem%20Med%20Chem&amp;title=Inhibition%20of%20hERG%20channel%20trafficking:%20an%20under%E2%80%90explored%20mechanism%20for%20drug%E2%80%90induced%20QT%20prolongation&amp;author=K%E2%80%90S%20Yeung&amp;author=NA%20Meanwell&amp;volume=3&amp;publication_year=2008&amp;pages=1501-1502&amp;pmid=18696522&amp;doi=10.1002/cmdc.200800170&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0008">
<span class="label">8.</span><cite>
Anon
. Recommended voltage protocols to study drug‐cardiac ion channel interactions using recombinant cell lines. <a href="https://www.fda.gov/media/131157/download" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.fda.gov/media/131157/download</a>. Accessed July 09, 2020.</cite>
</li>
<li id="prp21059-bib-0009">
<span class="label">9.</span><cite>
Passini E, Britton OJ, Lu HR, et al. Human in silico drug trials demonstrate higher accuracy than animal models in predicting clinical pro‐arrhythmic cardiotoxicity. Front Physiol. 2017;8:1‐15.</cite> [<a href="https://doi.org/10.3389/fphys.2017.00668" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5601077/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28955244/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Physiol&amp;title=Human%20in%20silico%20drug%20trials%20demonstrate%20higher%20accuracy%20than%20animal%20models%20in%20predicting%20clinical%20pro%E2%80%90arrhythmic%20cardiotoxicity&amp;author=E%20Passini&amp;author=OJ%20Britton&amp;author=HR%20Lu&amp;volume=8&amp;publication_year=2017&amp;pages=1-15&amp;pmid=28955244&amp;doi=10.3389/fphys.2017.00668&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0010">
<span class="label">10.</span><cite>
Passini E, Trovato C, Morissette P, Sannajust F, Bueno‐Orovio A, Rodriguez B. Drug‐induced shortening of the electromechanical window is an effective biomarker for in silico prediction of clinical risk of arrhythmias. Br J Pharmacol. 2019;176(19):3819‐3833.</cite> [<a href="https://doi.org/10.1111/bph.14786" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6780030/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31271649/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Pharmacol&amp;title=Drug%E2%80%90induced%20shortening%20of%20the%20electromechanical%20window%20is%20an%20effective%20biomarker%20for%20in%20silico%20prediction%20of%20clinical%20risk%20of%20arrhythmias&amp;author=E%20Passini&amp;author=C%20Trovato&amp;author=P%20Morissette&amp;author=F%20Sannajust&amp;author=A%20Bueno%E2%80%90Orovio&amp;volume=176&amp;issue=19&amp;publication_year=2019&amp;pages=3819-3833&amp;pmid=31271649&amp;doi=10.1111/bph.14786&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0011">
<span class="label">11.</span><cite>
Zhou X, Qu Y, Passini E, et al. Blinded in silico drug trial reveals the minimum set of ion channels for Torsades de pointes risk assessment. Front Pharmacol. 2020;10:1643. doi: 10.3389/fphar.2019.01643
</cite> [<a href="https://doi.org/10.3389/fphar.2019.01643" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7003137/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32082155/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Pharmacol&amp;title=Blinded%20in%20silico%20drug%20trial%20reveals%20the%20minimum%20set%20of%20ion%20channels%20for%20Torsades%20de%20pointes%20risk%20assessment&amp;author=X%20Zhou&amp;author=Y%20Qu&amp;author=E%20Passini&amp;volume=10&amp;publication_year=2020&amp;pages=1643&amp;pmid=32082155&amp;doi=10.3389/fphar.2019.01643&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0012">
<span class="label">12.</span><cite>
Delaunois A, Abernathy MM, Anderson WD, et al. Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off‐label in the first wave of COVID‐19. Clin Trans Sci. 2021;14:1133‐1146.</cite> [<a href="https://doi.org/10.1111/cts.13011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8014548/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33620150/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Trans%20Sci&amp;title=Applying%20the%20CiPA%20approach%20to%20evaluate%20cardiac%20proarrhythmia%20risk%20of%20some%20antimalarials%20used%20off%E2%80%90label%20in%20the%20first%20wave%20of%20COVID%E2%80%9019&amp;author=A%20Delaunois&amp;author=MM%20Abernathy&amp;author=WD%20Anderson&amp;volume=14&amp;publication_year=2021&amp;pages=1133-1146&amp;pmid=33620150&amp;doi=10.1111/cts.13011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0013">
<span class="label">13.</span><cite>
Tomek J, Bueno‐Orovio A, Passini E, et al. Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block. Elife. 2019;8:1, e48890‐47.</cite> [<a href="https://doi.org/10.7554/eLife.48890" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6970534/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31868580/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Elife&amp;title=Development,%20calibration,%20and%20validation%20of%20a%20novel%20human%20ventricular%20myocyte%20model%20in%20health,%20disease,%20and%20drug%20block&amp;author=J%20Tomek&amp;author=A%20Bueno%E2%80%90Orovio&amp;author=E%20Passini&amp;volume=8&amp;publication_year=2019&amp;pages=1-47&amp;pmid=31868580&amp;doi=10.7554/eLife.48890&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0014">
<span class="label">14.</span><cite>
O'Hara T, Virág L, Varró A, Rudy Y. Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation. PLoS Comput Biol. 2011;7(5):e1002061.</cite> [<a href="https://doi.org/10.1371/journal.pcbi.1002061" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3102752/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21637795/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Comput%20Biol&amp;title=Simulation%20of%20the%20undiseased%20human%20cardiac%20ventricular%20action%20potential:%20model%20formulation%20and%20experimental%20validation&amp;author=T%20O'Hara&amp;author=L%20Vir%C3%A1g&amp;author=A%20Varr%C3%B3&amp;author=Y%20Rudy&amp;volume=7&amp;issue=5&amp;publication_year=2011&amp;pages=e1002061&amp;pmid=21637795&amp;doi=10.1371/journal.pcbi.1002061&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0015">
<span class="label">15.</span><cite>
Dutta S, Chang KC, Beattie KA, et al. Optimization of an in silico cardiac cell model for proarrhythmia risk assessment. Front Physiol. 2017;8:616. doi: 10.3389/fphys.2017.00616
</cite> [<a href="https://doi.org/10.3389/fphys.2017.00616" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5572155/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28878692/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Physiol&amp;title=Optimization%20of%20an%20in%20silico%20cardiac%20cell%20model%20for%20proarrhythmia%20risk%20assessment&amp;author=S%20Dutta&amp;author=KC%20Chang&amp;author=KA%20Beattie&amp;volume=8&amp;publication_year=2017&amp;pages=616&amp;pmid=28878692&amp;doi=10.3389/fphys.2017.00616&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0016">
<span class="label">16.</span><cite>
Britton OJ, Bueno‐Orovio A, Van Ammel K, et al. Experimentally calibrated population of models predicts and explains intersubject variability in cardiac cellular electrophysiology. PNAS. 2013;110(23):E2098‐E2105.</cite> [<a href="https://doi.org/10.1073/pnas.1304382110" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3677477/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23690584/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PNAS&amp;title=Experimentally%20calibrated%20population%20of%20models%20predicts%20and%20explains%20intersubject%20variability%20in%20cardiac%20cellular%20electrophysiology&amp;author=OJ%20Britton&amp;author=A%20Bueno%E2%80%90Orovio&amp;author=K%20Van%20Ammel&amp;volume=110&amp;issue=23&amp;publication_year=2013&amp;pages=E2098-E2105&amp;pmid=23690584&amp;doi=10.1073/pnas.1304382110&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0017">
<span class="label">17.</span><cite>
Muszkiewicz A, Britton OJ, Gemmel P, et al. Variability in cardiac electrophysiology: using experimentally‐calibrated populations of models to move beyond the single virtual physiological human paradigm. Progr Biophys Mol Biol. 2016;120(1):115‐127.</cite> [<a href="https://doi.org/10.1016/j.pbiomolbio.2015.12.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4821179/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26701222/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Progr%20Biophys%20Mol%20Biol&amp;title=Variability%20in%20cardiac%20electrophysiology:%20using%20experimentally%E2%80%90calibrated%20populations%20of%20models%20to%20move%20beyond%20the%20single%20virtual%20physiological%20human%20paradigm&amp;author=A%20Muszkiewicz&amp;author=OJ%20Britton&amp;author=P%20Gemmel&amp;volume=120&amp;issue=1&amp;publication_year=2016&amp;pages=115-127&amp;pmid=26701222&amp;doi=10.1016/j.pbiomolbio.2015.12.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0018">
<span class="label">18.</span><cite>
Brennan T, Fink M, Rodriguez B. Multiscale modelling of drug‐induced effects on cardiac electrophysiological activity. Eur J Pharm Sci. 2009;36(1):62‐77.</cite> [<a href="https://doi.org/10.1016/j.ejps.2008.09.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19061955/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Pharm%20Sci&amp;title=Multiscale%20modelling%20of%20drug%E2%80%90induced%20effects%20on%20cardiac%20electrophysiological%20activity&amp;author=T%20Brennan&amp;author=M%20Fink&amp;author=B%20Rodriguez&amp;volume=36&amp;issue=1&amp;publication_year=2009&amp;pages=62-77&amp;pmid=19061955&amp;doi=10.1016/j.ejps.2008.09.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0019">
<span class="label">19.</span><cite>
Sarma JS, Sarma RJ, Bilitch M, Katz D, Song SL. An exponential formula for heart rate dependence of QT interval during exercise and cardiac pacing in humans: reevaluation of Bazett's formula. Am J Cardiol. 1984;54(1):103‐108. doi: 10.1016/0002-9149(84)90312-6
</cite> [<a href="https://doi.org/10.1016/0002-9149(84)90312-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6741799/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Cardiol&amp;title=An%20exponential%20formula%20for%20heart%20rate%20dependence%20of%20QT%20interval%20during%20exercise%20and%20cardiac%20pacing%20in%20humans:%20reevaluation%20of%20Bazett's%20formula&amp;author=JS%20Sarma&amp;author=RJ%20Sarma&amp;author=M%20Bilitch&amp;author=D%20Katz&amp;author=SL%20Song&amp;volume=54&amp;issue=1&amp;publication_year=1984&amp;pages=103-108&amp;pmid=6741799&amp;doi=10.1016/0002-9149(84)90312-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0020">
<span class="label">20.</span><cite>
Ramael S, De Smedt F, Toublanc N, et al. Single dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple‐dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects. Clin Therap. 2006;28(5):734‐744.</cite> [<a href="https://doi.org/10.1016/j.clinthera.2006.05.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16861095/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Therap&amp;title=Single%20dose%20bioavailability%20of%20levetiracetam%20intravenous%20infusion%20relative%20to%20oral%20tablets%20and%20multiple%E2%80%90dose%20pharmacokinetics%20and%20tolerability%20of%20levetiracetam%20intravenous%20infusion%20compared%20with%20placebo%20in%20healthy%20subjects&amp;author=S%20Ramael&amp;author=F%20De%20Smedt&amp;author=N%20Toublanc&amp;volume=28&amp;issue=5&amp;publication_year=2006&amp;pages=734-744&amp;pmid=16861095&amp;doi=10.1016/j.clinthera.2006.05.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0021">
<span class="label">21.</span><cite>
Klitgaard H, Matagne A, Gobert J, Wülfert E. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur J Pharmacol. 1998;353(2–3):191‐206.</cite> [<a href="https://doi.org/10.1016/s0014-2999(98)00410-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9726649/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Pharmacol&amp;title=Evidence%20for%20a%20unique%20profile%20of%20levetiracetam%20in%20rodent%20models%20of%20seizures%20and%20epilepsy&amp;author=H%20Klitgaard&amp;author=A%20Matagne&amp;author=J%20Gobert&amp;author=E%20W%C3%BClfert&amp;volume=353&amp;issue=2%E2%80%933&amp;publication_year=1998&amp;pages=191-206&amp;pmid=9726649&amp;doi=10.1016/s0014-2999(98)00410-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0022">
<span class="label">22.</span><cite>
Kramer J, Obejero‐Paz CA, Myatt G, et al. MICE models: superior to the HERG model in predicting torsade de pointes. Sci Rep. 2013;3:2100. doi: 10.1038/srep02100
</cite> [<a href="https://doi.org/10.1038/srep02100" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3696896/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23812503/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=MICE%20models:%20superior%20to%20the%20HERG%20model%20in%20predicting%20torsade%20de%20pointes&amp;author=J%20Kramer&amp;author=CA%20Obejero%E2%80%90Paz&amp;author=G%20Myatt&amp;volume=3&amp;publication_year=2013&amp;pages=2100&amp;pmid=23812503&amp;doi=10.1038/srep02100&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0023">
<span class="label">23.</span><cite>
Wallis RM. Integrated risk assessment and predictive value to humans of non‐clinical repolarization assays. Br J Pharmacol. 2010;159:115‐121.</cite> [<a href="https://doi.org/10.1111/j.1476-5381.2009.00395.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2823357/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19785646/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Pharmacol&amp;title=Integrated%20risk%20assessment%20and%20predictive%20value%20to%20humans%20of%20non%E2%80%90clinical%20repolarization%20assays&amp;author=RM%20Wallis&amp;volume=159&amp;publication_year=2010&amp;pages=115-121&amp;pmid=19785646&amp;doi=10.1111/j.1476-5381.2009.00395.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0024">
<span class="label">24.</span><cite>
Redfern WS, Carlsson L, Davis AS, et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res. 2003;58:32‐45.</cite> [<a href="https://doi.org/10.1016/s0008-6363(02)00846-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12667944/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiovasc%20Res&amp;title=Relationships%20between%20preclinical%20cardiac%20electrophysiology,%20clinical%20QT%20interval%20prolongation%20and%20torsade%20de%20pointes%20for%20a%20broad%20range%20of%20drugs:%20evidence%20for%20a%20provisional%20safety%20margin%20in%20drug%20development&amp;author=WS%20Redfern&amp;author=L%20Carlsson&amp;author=AS%20Davis&amp;volume=58&amp;publication_year=2003&amp;pages=32-45&amp;pmid=12667944&amp;doi=10.1016/s0008-6363(02)00846-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0025">
<span class="label">25.</span><cite>
Leishman DJ, Abernathy MM, Wang EB. Revisiting the hERG safety margin after 20 years of routine hERG screening. J Pharmacol Toxicol Methods. 2020;105:106900.</cite> [<a href="https://doi.org/10.1016/j.vascn.2020.106900" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32768644/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pharmacol%20Toxicol%20Methods&amp;title=Revisiting%20the%20hERG%20safety%20margin%20after%2020%E2%80%89years%20of%20routine%20hERG%20screening&amp;author=DJ%20Leishman&amp;author=MM%20Abernathy&amp;author=EB%20Wang&amp;volume=105&amp;publication_year=2020&amp;pages=106900&amp;pmid=32768644&amp;doi=10.1016/j.vascn.2020.106900&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0026">
<span class="label">26.</span><cite>
Gintant GA, Limberis JTT, McDermott JS, Wegner CD, Cox BF. The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug‐induced arrhythmogenesis. J Cardiovasc Pharmacol. 2001;37(5):607‐618.</cite> [<a href="https://doi.org/10.1097/00005344-200105000-00012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11336111/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Cardiovasc%20Pharmacol&amp;title=The%20canine%20Purkinje%20fiber:%20an%20in%20vitro%20model%20system%20for%20acquired%20long%20QT%20syndrome%20and%20drug%E2%80%90induced%20arrhythmogenesis&amp;author=GA%20Gintant&amp;author=JTT%20Limberis&amp;author=JS%20McDermott&amp;author=CD%20Wegner&amp;author=BF%20Cox&amp;volume=37&amp;issue=5&amp;publication_year=2001&amp;pages=607-618&amp;pmid=11336111&amp;doi=10.1097/00005344-200105000-00012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0027">
<span class="label">27.</span><cite>
Kurita T, Ohe T, Marui N, et al. Bradycardia‐induced abnormal QT prolongation in patients with complete atrioventricular block with torsades de pointes. Am J Cardiol. 1992;69(6):628‐633. doi: 10.1016/0002-9149(92)90154-q
</cite> [<a href="https://doi.org/10.1016/0002-9149(92)90154-q" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1536113/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Cardiol&amp;title=Bradycardia%E2%80%90induced%20abnormal%20QT%20prolongation%20in%20patients%20with%20complete%20atrioventricular%20block%20with%20torsades%20de%20pointes&amp;author=T%20Kurita&amp;author=T%20Ohe&amp;author=N%20Marui&amp;volume=69&amp;issue=6&amp;publication_year=1992&amp;pages=628-633&amp;pmid=1536113&amp;doi=10.1016/0002-9149(92)90154-q&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0028">
<span class="label">28.</span><cite>
FAERS
Database accessed through PharmaPendium®. Amsterdam, Netherlands: Elsevier. Updated August 12, 2020. 
<a href="https://www.pharmapendium.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.pharmapendium.com</a>. Accessed 25 March 2021.</cite>
</li>
<li id="prp21059-bib-0029">
<span class="label">29.</span><cite>
Kallergis EM, Goudis CA, Simantirakis EN, Kochiadakis GE, Vardas PE. Mechanisms, risk factors, and management of acquired long QT syndrome: a comprehensive review. Sci World J. 2012;2012:212178.</cite> [<a href="https://doi.org/10.1100/2012/212178" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3347892/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22593664/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20World%20J&amp;title=Mechanisms,%20risk%20factors,%20and%20management%20of%20acquired%20long%20QT%20syndrome:%20a%20comprehensive%20review&amp;author=EM%20Kallergis&amp;author=CA%20Goudis&amp;author=EN%20Simantirakis&amp;author=GE%20Kochiadakis&amp;author=PE%20Vardas&amp;volume=2012&amp;publication_year=2012&amp;pages=212178&amp;pmid=22593664&amp;doi=10.1100/2012/212178&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0030">
<span class="label">30.</span><cite>
Valentin JP, Hoffmann P, Ortemann‐Renon C, et al. The challenge of predicting drug‐induced QTc prolongation in humans. Tox Sci. 2022;187(1):3‐24.</cite> [<a href="https://doi.org/10.1093/toxsci/kfac013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9041548/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35148401/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Tox%20Sci&amp;title=The%20challenge%20of%20predicting%20drug%E2%80%90induced%20QTc%20prolongation%20in%20humans&amp;author=JP%20Valentin&amp;author=P%20Hoffmann&amp;author=C%20Ortemann%E2%80%90Renon&amp;volume=187&amp;issue=1&amp;publication_year=2022&amp;pages=3-24&amp;pmid=35148401&amp;doi=10.1093/toxsci/kfac013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0031">
<span class="label">31.</span><cite>
Issa NP, Fisher WG, Narayanan JT. QT interval prolongation in a patient with LQT2 on levetiracetam. Seizure. 2015;29:134‐136.</cite> [<a href="https://doi.org/10.1016/j.seizure.2015.04.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26076856/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Seizure&amp;title=QT%20interval%20prolongation%20in%20a%20patient%20with%20LQT2%20on%20levetiracetam&amp;author=NP%20Issa&amp;author=WG%20Fisher&amp;author=JT%20Narayanan&amp;volume=29&amp;publication_year=2015&amp;pages=134-136&amp;pmid=26076856&amp;doi=10.1016/j.seizure.2015.04.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0032">
<span class="label">32.</span><cite>
Galtrey CM, Levee V, Arevalo J, Wren D. Long QT syndrome masquerading as epilepsy. Pract Neurol. 2019;19:56‐61.</cite> [<a href="https://doi.org/10.1136/practneurol-2018-001959" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30323052/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pract%20Neurol&amp;title=Long%20QT%20syndrome%20masquerading%20as%20epilepsy&amp;author=CM%20Galtrey&amp;author=V%20Levee&amp;author=J%20Arevalo&amp;author=D%20Wren&amp;volume=19&amp;publication_year=2019&amp;pages=56-61&amp;pmid=30323052&amp;doi=10.1136/practneurol-2018-001959&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0033">
<span class="label">33.</span><cite>
Männikkö R, Overend G, Perrey C, et al. Pharmacological and electrophysiological characterization of nine, single nucleotide polymorphisms of the hERG‐encoded potassium channel. Br J Pharmacol. 2010;159:102‐114.</cite> [<a href="https://doi.org/10.1111/j.1476-5381.2009.00334.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2823356/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19673885/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Pharmacol&amp;title=Pharmacological%20and%20electrophysiological%20characterization%20of%20nine,%20single%20nucleotide%20polymorphisms%20of%20the%20hERG%E2%80%90encoded%20potassium%20channel&amp;author=R%20M%C3%A4nnikk%C3%B6&amp;author=G%20Overend&amp;author=C%20Perrey&amp;volume=159&amp;publication_year=2010&amp;pages=102-114&amp;pmid=19673885&amp;doi=10.1111/j.1476-5381.2009.00334.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0034">
<span class="label">34.</span><cite>
Nei M. Cardiac effects of seizures. Epilepsy Curr. 2009;9(4):91‐95.</cite> [<a href="https://doi.org/10.1111/j.1535-7511.2009.01303.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2728482/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19693322/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Epilepsy%20Curr&amp;title=Cardiac%20effects%20of%20seizures&amp;author=M%20Nei&amp;volume=9&amp;issue=4&amp;publication_year=2009&amp;pages=91-95&amp;pmid=19693322&amp;doi=10.1111/j.1535-7511.2009.01303.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0035">
<span class="label">35.</span><cite>
Surges R, Adjei P, Kallis C, et al. Pathologic cardiac repolarization in pharmacoresistant epilepsy and its potential role in sudden unexpected death in epilepsy: a case‐control study. Epilepsia. 2010;51(2):233‐242.</cite> [<a href="https://doi.org/10.1111/j.1528-1167.2009.02330.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19817816/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Epilepsia&amp;title=Pathologic%20cardiac%20repolarization%20in%20pharmacoresistant%20epilepsy%20and%20its%20potential%20role%20in%20sudden%20unexpected%20death%20in%20epilepsy:%20a%20case%E2%80%90control%20study&amp;author=R%20Surges&amp;author=P%20Adjei&amp;author=C%20Kallis&amp;volume=51&amp;issue=2&amp;publication_year=2010&amp;pages=233-242&amp;pmid=19817816&amp;doi=10.1111/j.1528-1167.2009.02330.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0036">
<span class="label">36.</span><cite>
Lee S, Harris ND, Robinson RT, Yeoh L, Macdonald IA, Heller SR. Effects of adrenaline and potassium on QTc interval and QT dispersion in man. Eur J Clin Invest. 2003;33(2):93‐98.</cite> [<a href="https://doi.org/10.1046/j.1365-2362.2003.01123.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12588281/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Clin%20Invest&amp;title=Effects%20of%20adrenaline%20and%20potassium%20on%20QTc%20interval%20and%20QT%20dispersion%20in%20man&amp;author=S%20Lee&amp;author=ND%20Harris&amp;author=RT%20Robinson&amp;author=L%20Yeoh&amp;author=IA%20Macdonald&amp;volume=33&amp;issue=2&amp;publication_year=2003&amp;pages=93-98&amp;pmid=12588281&amp;doi=10.1046/j.1365-2362.2003.01123.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0037">
<span class="label">37.</span><cite>
Roche F, Reynaud C, Pichot V, et al. Effect of acute hypoxia on QT rate dependence and corrected QT interval in healthy subjects. Am J Cardiol. 2003;91(7):916‐919.</cite> [<a href="https://doi.org/10.1016/s0002-9149(03)00040-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12667592/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Cardiol&amp;title=Effect%20of%20acute%20hypoxia%20on%20QT%20rate%20dependence%20and%20corrected%20QT%20interval%20in%20healthy%20subjects&amp;author=F%20Roche&amp;author=C%20Reynaud&amp;author=V%20Pichot&amp;volume=91&amp;issue=7&amp;publication_year=2003&amp;pages=916-919&amp;pmid=12667592&amp;doi=10.1016/s0002-9149(03)00040-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0038">
<span class="label">38.</span><cite>
Kiely DG, Cargill RI, Lipworth BJ. Effects of hypercapnia on hemodynamic, inotropic, lusitropic, and electrophysiologic indices in humans. Chest. 1996;109(5):1215‐1221.</cite> [<a href="https://doi.org/10.1378/chest.109.5.1215" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8625670/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;title=Effects%20of%20hypercapnia%20on%20hemodynamic,%20inotropic,%20lusitropic,%20and%20electrophysiologic%20indices%20in%20humans&amp;author=DG%20Kiely&amp;author=RI%20Cargill&amp;author=BJ%20Lipworth&amp;volume=109&amp;issue=5&amp;publication_year=1996&amp;pages=1215-1221&amp;pmid=8625670&amp;doi=10.1378/chest.109.5.1215&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="prp21059-bib-0039">
<span class="label">39.</span><cite>
Tatschl C, Stöllberger C, Matz K, et al. Insular involvement is associated with QT prolongation: ECG abnormalities in patients with acute stroke. Cerebrovasc Dis. 2006;21(1–2):47‐53.</cite> [<a href="https://doi.org/10.1159/000089594" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16282690/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cerebrovasc%20Dis&amp;title=Insular%20involvement%20is%20associated%20with%20QT%20prolongation:%20ECG%20abnormalities%20in%20patients%20with%20acute%20stroke&amp;author=C%20Tatschl&amp;author=C%20St%C3%B6llberger&amp;author=K%20Matz&amp;volume=21&amp;issue=1%E2%80%932&amp;publication_year=2006&amp;pages=47-53&amp;pmid=16282690&amp;doi=10.1159/000089594&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><p>
Appendix S1.
</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9903303/bin/PRP2-11-e01059-s002.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (53.4KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p"><p>
Table S1.
</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9903303/bin/PRP2-11-e01059-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (14.3KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets generated for the present work are available from the corresponding author upon reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Pharmacology Research &amp; Perspectives are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1002/prp2.1059"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/PRP2-11-e01059.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.6 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/9903303/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/9903303/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9903303%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9903303/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC9903303/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC9903303/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/36748725/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC9903303/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/36748725/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC9903303/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/9903303/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="o5bniHZgm84X5I8LHO83xWETgHpwW2ZxjgJcwX8Srv0LwxrGwTjorEXmQduXvbC9">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
        <script type="module" crossorigin="" src="/static/assets/math-574fdcc6.js"></script>
    
    

    </body>
</html>
